BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McGuigan A, Kelly P, Turkington RC, Jones C, Coleman HG, McCain RS. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol 2018; 24(43): 4846-4861 [PMID: 30487695 DOI: 10.3748/wjg.v24.i43.4846] [Cited by in CrossRef: 399] [Cited by in F6Publishing: 326] [Article Influence: 99.8] [Reference Citation Analysis]
Number Citing Articles
1 Kaissis G, Braren R. Pancreatic cancer detection and characterization-state of the art cross-sectional imaging and imaging data analysis. Transl Gastroenterol Hepatol 2019;4:35. [PMID: 31231702 DOI: 10.21037/tgh.2019.05.04] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
2 Borowicz S, Principe DR, Dorman MJ, McHenry AJ, Sondarva G, Kumar S, Ananthanarayanan V, Simms PE, Hess A, Rana A. HAI-1 is an independent predictor of lung cancer mortality and is required for M1 macrophage polarization. PLoS One 2021;16:e0252197. [PMID: 34185790 DOI: 10.1371/journal.pone.0252197] [Reference Citation Analysis]
3 Gao CT, Ren J, Yu J, Li SN, Guo XF, Zhou YZ. KIF23 enhances cell proliferation in pancreatic ductal adenocarcinoma and is a potent therapeutic target. Ann Transl Med 2020;8:1394. [PMID: 33313139 DOI: 10.21037/atm-20-1970] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
4 Wei AL, Li M, Li GQ, Wang X, Hu WM, Li ZL, Yuan J, Liu HY, Zhou LL, Li K, Li A, Fu MR. Oral microbiome and pancreatic cancer. World J Gastroenterol 2020; 26(48): 7679-7692 [PMID: 33505144 DOI: 10.3748/wjg.v26.i48.7679] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
5 Tiffon C. Defining Parallels between the Salivary Glands and Pancreas to Better Understand Pancreatic Carcinogenesis. Biomedicines 2020;8:E178. [PMID: 32604970 DOI: 10.3390/biomedicines8060178] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Yang C, Li Y, Hu W, Wang X, Hu J, Yuan C, Zhou C, Wang H, Du J, Wang Y, Tong X. TEOA Promotes Autophagic Cell Death via ROS-Mediated Inhibition of mTOR/p70S6k Signaling Pathway in Pancreatic Cancer Cells. Front Cell Dev Biol 2021;9:734818. [PMID: 34692691 DOI: 10.3389/fcell.2021.734818] [Reference Citation Analysis]
7 Farias AJ, Streicher SA, Stram DO, Wang S, Pandol SJ, Le Marchand L, Setiawan VW. Racial/ethnic disparities in weight or BMI change in adulthood and pancreatic cancer incidence: The multiethnic cohort. Cancer Med 2021;10:4097-106. [PMID: 33998145 DOI: 10.1002/cam4.3958] [Reference Citation Analysis]
8 Xu H, Mao J, Yang X, Chen F, Song Z, Fei J, Chen W, Zhong Z, Wang X. AMP‑activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas. Mol Med Rep 2020;22:4329-39. [PMID: 33000197 DOI: 10.3892/mmr.2020.11504] [Reference Citation Analysis]
9 Ahmed SA, Parama D, Daimari E, Girisa S, Banik K, Harsha C, Dutta U, Kunnumakkara AB. Rationalizing the therapeutic potential of apigenin against cancer. Life Sci 2021;267:118814. [PMID: 33333052 DOI: 10.1016/j.lfs.2020.118814] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
10 Schawkat K, Manning MA, Glickman JN, Mortele KJ. Pancreatic Ductal Adenocarcinoma and Its Variants: Pearls and Perils. Radiographics 2020;40:1219-39. [PMID: 32678699 DOI: 10.1148/rg.2020190184] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
11 Schlick K, Kiem D, Huemer F, Neureiter D, Weiss L, Greil R. Non-pegylated Liposomal Doxorubicin as Palliative Chemotherapy in pre-Treated Advanced Pancreatic Cancer: A Retrospective Analysis of Twenty-Eight Patients. Technol Cancer Res Treat 2021;20:15330338211042139. [PMID: 34595977 DOI: 10.1177/15330338211042139] [Reference Citation Analysis]
12 Matsumoto Y, Fukumitsu N, Ishikawa H, Nakai K, Sakurai H. A Critical Review of Radiation Therapy: From Particle Beam Therapy (Proton, Carbon, and BNCT) to Beyond. J Pers Med 2021;11:825. [PMID: 34442469 DOI: 10.3390/jpm11080825] [Reference Citation Analysis]
13 Fiorentini G, Sarti D, Casadei V, Milandri C, Dentico P, Mambrini A, Nani R, Fiorentini C, Guadagni S. Modulated Electro-Hyperthermia as Palliative Treatment for Pancreatic Cancer: A Retrospective Observational Study on 106 Patients.Integr Cancer Ther. 2019;18:1534735419878505. [PMID: 31561722 DOI: 10.1177/1534735419878505] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
14 Lei Y, Yu T, Li C, Li J, Liang Y, Wang X, Chen Y, Wang X. Expression of CAMK1 and its association with clinicopathologic characteristics in pancreatic cancer. J Cell Mol Med 2021;25:1198-206. [PMID: 33342045 DOI: 10.1111/jcmm.16188] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Nucci D, Santangelo OE, Provenzano S, Fatigoni C, Nardi M, Ferrara P, Gianfredi V. Dietary Fiber Intake and Risk of Pancreatic Cancer: Systematic Review and Meta-Analysis of Observational Studies. Int J Environ Res Public Health 2021;18:11556. [PMID: 34770068 DOI: 10.3390/ijerph182111556] [Reference Citation Analysis]
16 Wang X, Shan YQ, Tan QQ, Tan CL, Zhang H, Liu JH, Ke NW, Chen YH, Liu XB. MEX3A knockdown inhibits the development of pancreatic ductal adenocarcinoma. Cancer Cell Int 2020;20:63. [PMID: 32140076 DOI: 10.1186/s12935-020-1146-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
17 Harvitkar RU, Peri H, Zallipalli SN, Joseph SJ, Gattupalli GB, Ansari K. Non-Cancer Causes of Death in Patients With Pancreatic Adenocarcinoma: A Surveillance, Epidemiology, and End Results (SEER)-Based Study. Cureus 2021;13:e20289. [PMID: 34926091 DOI: 10.7759/cureus.20289] [Reference Citation Analysis]
18 De Dosso S, Siebenhüner AR, Winder T, Meisel A, Fritsch R, Astaras C, Szturz P, Borner M. Treatment landscape of metastatic pancreatic cancer. Cancer Treat Rev 2021;96:102180. [PMID: 33812339 DOI: 10.1016/j.ctrv.2021.102180] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
19 Burns EA, Kasparian S, Khan U, Abdelrahim M. Pancreatic adenocarcinoma with early esophageal metastasis: A case report and review of literature. World J Clin Oncol 2020; 11(2): 83-90 [PMID: 32133277 DOI: 10.5306/wjco.v11.i2.83] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Zimmermann MT, Mathison AJ, Stodola T, Evans DB, Abrudan JL, Demos W, Tschannen M, Aldakkak M, Geurts J, Lomberk G, Tsai S, Urrutia R. Interpreting Sequence Variation in PDAC-Predisposing Genes Using a Multi-Tier Annotation Approach Performed at the Gene, Patient, and Cohort Level. Front Oncol 2021;11:606820. [PMID: 33747920 DOI: 10.3389/fonc.2021.606820] [Reference Citation Analysis]
21 Forni C, Rossi M, Borromeo I, Feriotto G, Platamone G, Tabolacci C, Mischiati C, Beninati S. Flavonoids: A Myth or a Reality for Cancer Therapy? Molecules 2021;26:3583. [PMID: 34208196 DOI: 10.3390/molecules26123583] [Reference Citation Analysis]
22 Li Y, Su Z, Wei B, Liang Z. KRT7 Overexpression is Associated with Poor Prognosis and Immune Cell Infiltration in Patients with Pancreatic Adenocarcinoma. Int J Gen Med 2021;14:2677-94. [PMID: 34188523 DOI: 10.2147/IJGM.S313584] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Tan M, Brusgaard K, Gerdes AM, Mortensen MB, Detlefsen S, Schaffalitzky de Muckadell OB, Joergensen MT. Cohort profile and heritability assessment of familial pancreatic cancer: a nation-wide study. Scand J Gastroenterol 2021;56:965-71. [PMID: 34165379 DOI: 10.1080/00365521.2021.1937697] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Fitzpatrick MJ, Hernandez-Barco YG, Krishnan K, Casey B, Pitman MB. Evaluating triage protocols for endoscopic ultrasound-guided fine needle biopsies of the pancreas. J Am Soc Cytopathol 2020;9:396-404. [PMID: 32620535 DOI: 10.1016/j.jasc.2020.05.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Ma X, Wang YR, Zhuo LY, Yin XP, Ren JL, Li CY, Xing LH, Zheng TT. Retrospective Analysis of the Value of Enhanced CT Radiomics Analysis in the Differential Diagnosis Between Pancreatic Cancer and Chronic Pancreatitis. Int J Gen Med 2022;15:233-41. [PMID: 35023961 DOI: 10.2147/IJGM.S337455] [Reference Citation Analysis]
26 Kong L, Liu P, Zheng M, Xue B, Liang K, Tan X. Multi-omics analysis based on integrated genomics, epigenomics and transcriptomics in pancreatic cancer. Epigenomics 2020;12:507-24. [PMID: 32048534 DOI: 10.2217/epi-2019-0374] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
27 Solanki A, King D, Thibault G, Wang L, Gibbs SL. Quantification of fluorophore distribution and therapeutic response in matched in vivo and ex vivo pancreatic cancer model systems. PLoS One 2020;15:e0229407. [PMID: 32097436 DOI: 10.1371/journal.pone.0229407] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Fergus J, Nelson DW, Sung M, Lee D, Lavotshkin S, Difronzo LA, O'Connor VV. Pancreatectomy in Stage I pancreas cancer: national underutilization of surgery persists. HPB (Oxford) 2020;22:1703-10. [PMID: 32331911 DOI: 10.1016/j.hpb.2020.03.017] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Zhao Z, Liu W. Pancreatic Cancer: A Review of Risk Factors, Diagnosis, and Treatment. Technol Cancer Res Treat 2020;19:1533033820962117. [PMID: 33357065 DOI: 10.1177/1533033820962117] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Chiu CF, Chang HY, Huang CY, Mau CZ, Kuo TT, Lee HC, Huang SY. Betulinic Acid Affects the Energy-Related Proteomic Profiling in Pancreatic Ductal Adenocarcinoma Cells. Molecules 2021;26:2482. [PMID: 33923185 DOI: 10.3390/molecules26092482] [Reference Citation Analysis]
31 Darnell EP, Wang TJ, Lumish MA, Hernandez-Barco YG, Weniger M, Casey BW, Qadan M, Lillemoe KD, Ferrone CR, Fernandez-Del Castillo C, Krishnan K. Preoperative cholangitis is an independent risk factor for mortality in patients after pancreatoduodenectomy for pancreatic cancer. Am J Surg 2021;221:134-40. [PMID: 32847686 DOI: 10.1016/j.amjsurg.2020.07.025] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Lippi G, Mattiuzzi C. The global burden of pancreatic cancer. Arch Med Sci 2020;16:820-4. [PMID: 32542083 DOI: 10.5114/aoms.2020.94845] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
33 Sun LL, Cheng M, Xu XD. MicroRNA-30c inhibits pancreatic cancer cell proliferation by targeting twinfilin 1 and indicates a poor prognosis. World J Gastroenterol 2019; 25(42): 6311-6321 [PMID: 31754292 DOI: 10.3748/wjg.v25.i42.6311] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
34 Wang M, Xie F, Lin J, Zhao Y, Zhang Q, Liao Z, Wei P. Diagnostic and Prognostic Value of Circulating CircRNAs in Cancer. Front Med (Lausanne) 2021;8:649383. [PMID: 33816529 DOI: 10.3389/fmed.2021.649383] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
35 Asar MC, Franco A, Soendergaard M. Phage Display Selection, Identification, and Characterization of Novel Pancreatic Cancer Targeting Peptides. Biomolecules 2020;10:E714. [PMID: 32380649 DOI: 10.3390/biom10050714] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Terlizzi M, Buscail E, Boussari O, Adgié S, Leduc N, Terrebonne E, Smith D, Blanc JF, Lapuyade B, Laurent C, Chiche L, Belleannée G, Le Malicot K, Trouette R, Pouypoudat C, Vendrely V. Neoadjuvant treatment for borderline resectable pancreatic adenocarcinoma is associated with higher R0 rate compared to upfront surgery. Acta Oncol 2021;60:1114-21. [PMID: 34197269 DOI: 10.1080/0284186X.2021.1944662] [Reference Citation Analysis]
37 Chang J, Hu X, Nan J, Zhang X, Jin X. HOXD9‑induced SCNN1A upregulation promotes pancreatic cancer cell proliferation, migration and predicts prognosis by regulating epithelial‑mesenchymal transformation. Mol Med Rep 2021;24:819. [PMID: 34558641 DOI: 10.3892/mmr.2021.12459] [Reference Citation Analysis]
38 He LH, He YL, Zuo WH, Kang Y, Xue H, Wang LY, Zhang YL, Meng Y. Neuropilin1 silencing impairs the proliferation and migration of cells in pancreatic cancer. J Clin Lab Anal 2020;34:e23394. [PMID: 32472711 DOI: 10.1002/jcla.23394] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Supadmanaba IGP, Mantini G, Randazzo O, Capula M, Muller IB, Cascioferro S, Diana P, Peters GJ, Giovannetti E. Interrelationship between miRNA and splicing factors in pancreatic ductal adenocarcinoma. Epigenetics 2021;:1-24. [PMID: 34057028 DOI: 10.1080/15592294.2021.1916697] [Reference Citation Analysis]
40 Chan S, Wassef W. Endoscopic Ultrasound-Guided Fine-Needle Aspiration for Diagnosis of Pancreatic Metastases Secondary to Ovarian Carcinoma. ACG Case Rep J 2021;8:e00544. [PMID: 33654704 DOI: 10.14309/crj.0000000000000544] [Reference Citation Analysis]
41 Yao X, Mao Y, Wu D, Zhu Y, Lu J, Huang Y, Guo Y, Wang Z, Zhu S, Li X, Lu Y. Exosomal circ_0030167 derived from BM-MSCs inhibits the invasion, migration, proliferation and stemness of pancreatic cancer cells by sponging miR-338-5p and targeting the Wif1/Wnt8/β-catenin axis. Cancer Lett 2021;512:38-50. [PMID: 33971282 DOI: 10.1016/j.canlet.2021.04.030] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Shim MK, Na J, Cho IK, Jang EH, Park J, Lee S, Kim J. Targeting of claudin-4 by Clostridium perfringens enterotoxin-conjugated polysialic acid nanoparticles for pancreatic cancer therapy. Journal of Controlled Release 2021;331:434-42. [DOI: 10.1016/j.jconrel.2021.01.031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
43 Fritz I, Wagner P, Olsson H. Improved survival in several cancers with use of H1-antihistamines desloratadine and loratadine. Transl Oncol 2021;14:101029. [PMID: 33550204 DOI: 10.1016/j.tranon.2021.101029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
44 Ligeiro D, Rao M, Maia A, Castillo M, Beltran A, Maeurer M. B Cells in the Gastrointestinal Tumor Microenvironment with a Focus on Pancreatic Cancer: Opportunities for Precision Medicine? Adv Exp Med Biol 2020;1273:175-95. [PMID: 33119882 DOI: 10.1007/978-3-030-49270-0_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Dogra P, Ramírez JR, Peláez MJ, Wang Z, Cristini V, Parasher G, Rawat M. Mathematical Modeling to Address Challenges in Pancreatic Cancer. Curr Top Med Chem 2020;20:367-76. [PMID: 31893993 DOI: 10.2174/1568026620666200101095641] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
46 Hu JX, Zhao CF, Chen WB, Liu QC, Li QW, Lin YY, Gao F. Pancreatic cancer: A review of epidemiology, trend, and risk factors. World J Gastroenterol 2021; 27(27): 4298-4321 [PMID: 34366606 DOI: 10.3748/wjg.v27.i27.4298] [Reference Citation Analysis]
47 Ay S, Atcı MM, Arıkan R, Dülgar Ö, Özyükseler DT, Paksoy N, Doğan İ, Öztosun B, Taştekin D, Öven BB, Gümüş M. FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer. J Chemother 2022;:1-7. [PMID: 35037592 DOI: 10.1080/1120009X.2022.2026125] [Reference Citation Analysis]
48 Oyeneyin OE, Obadawo BS, Olanrewaju AA, Owolabi TO, Gbadamosi FA, Ipinloju N, Modamori HO. Predicting the bioactivity of 2-alkoxycarbonylallyl esters as potential antiproliferative agents against pancreatic cancer (MiaPaCa-2) cell lines: GFA-based QSAR and ELM-based models with molecular docking. J Genet Eng Biotechnol 2021;19:38. [PMID: 33689046 DOI: 10.1186/s43141-021-00133-2] [Reference Citation Analysis]
49 Bazzichetto C, Conciatori F, Luchini C, Simionato F, Santoro R, Vaccaro V, Corbo V, Falcone I, Ferretti G, Cognetti F, Melisi D, Scarpa A, Ciuffreda L, Milella M. From Genetic Alterations to Tumor Microenvironment: The Ariadne's String in Pancreatic Cancer. Cells 2020;9:E309. [PMID: 32012917 DOI: 10.3390/cells9020309] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
50 Castillo Tuñón JM, Valle Rodas ME, Botello Martínez F, Rojas Holguín A, López Guerra D, Santos Naharro J, Jaén Torrejímeno I, Blanco Fernández G. Implementation of a regional reference center in pancreatic surgery. Experience after 631 procedures. Cir Esp (Engl Ed) 2020:S0009-739X(20)30313-4. [PMID: 33342520 DOI: 10.1016/j.ciresp.2020.09.013] [Reference Citation Analysis]
51 Xiong X, Feng J, Yang X, Li H, Shi Q, Tao J, Chang J. Circular RNA CDR1as promotes tumor progression by regulating miR-432-5p/E2F3 axis in pancreatic cancer. Cancer Cell Int 2021;21:112. [PMID: 33593338 DOI: 10.1186/s12935-021-01812-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
52 Mallik MK, Kapila K, Mohanty AK, Inamdar SA, AlAli A, Al Naseer A. Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology of Pancreatic Adenocarcinomas Revisited. A Detailed Cytological Analysis. J Cytol 2021;38:31-7. [PMID: 33935389 DOI: 10.4103/JOC.JOC_177_20] [Reference Citation Analysis]
53 Hendricks-Wenger A, Aycock KN, Nagai-Singer MA, Coutermarsh-Ott S, Lorenzo MF, Gannon J, Uh K, Farrell K, Beitel-White N, Brock RM, Simon A, Morrison HA, Tuohy J, Clark-Deener S, Vlaisavljevich E, Davalos RV, Lee K, Allen IC. Establishing an immunocompromised porcine model of human cancer for novel therapy development with pancreatic adenocarcinoma and irreversible electroporation. Sci Rep 2021;11:7584. [PMID: 33828203 DOI: 10.1038/s41598-021-87228-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
54 Supadmanaba IGP, Comandatore A, Morelli L, Giovannetti E, Lagerweij T. Organotypic-liver slide culture systems to explore the role of extracellular vesicles in pancreatic cancer metastatic behavior and guide new therapeutic approaches. Expert Opin Drug Metab Toxicol 2021;17:937-46. [PMID: 33945374 DOI: 10.1080/17425255.2021.1925646] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Tonozuka R, Mukai S, Itoi T. The Role of Artificial Intelligence in Endoscopic Ultrasound for Pancreatic Disorders. Diagnostics (Basel). 2020;11. [PMID: 33374181 DOI: 10.3390/diagnostics11010018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
56 Lee JE, Kang YW, Jung KH, Son MK, Shin SM, Kim JS, Kim SJ, Fang Z, Yan HH, Park JH, Yoon YC, Han B, Cheon MJ, Woo MG, Seo MS, Lim JH, Kim YS, Hong SS. Intracellular KRAS-specific antibody enhances the anti-tumor efficacy of gemcitabine in pancreatic cancer by inducing endosomal escape. Cancer Lett 2021;507:97-111. [PMID: 33744388 DOI: 10.1016/j.canlet.2021.03.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
57 De Rosa P, Jewell A. The potential use for patient reported outcome measures in people with pancreatic cancer, with a specific focus on older patients. European Journal of Surgical Oncology 2021;47:495-502. [DOI: 10.1016/j.ejso.2020.05.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
58 Takahashi K, Ehata S, Miyauchi K, Morishita Y, Miyazawa K, Miyazono K. Neurotensin receptor 1 signaling promotes pancreatic cancer progression. Mol Oncol 2021;15:151-66. [PMID: 33034134 DOI: 10.1002/1878-0261.12815] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
59 Zhu Y, Tian J, Peng X, Wang X, Yang N, Ying P, Wang H, Li B, Li Y, Zhang M, Cai Y, Lu Z, Niu S, Li Y, Zhong R, Chang J, Miao X. A genetic variant conferred high expression of CAV2 promotes pancreatic cancer progression and associates with poor prognosis. Eur J Cancer 2021;151:94-105. [PMID: 33975060 DOI: 10.1016/j.ejca.2021.04.008] [Reference Citation Analysis]
60 Buscail E, Chauvet A, Quincy P, Degrandi O, Buscail C, Lamrissi I, Moranvillier I, Caumont C, Verdon S, Brisson A, Marty M, Chiche L, Laurent C, Vendrely V, Moreau-Gaudry F, Bedel A, Dabernat S. CD63-GPC1-Positive Exosomes Coupled with CA19-9 Offer Good Diagnostic Potential for Resectable Pancreatic Ductal Adenocarcinoma. Transl Oncol 2019;12:1395-403. [PMID: 31400579 DOI: 10.1016/j.tranon.2019.07.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
61 Inoue H, Eguchi A, Kobayashi Y, Usugi E, Yamada R, Tsuboi J, Akuta T, Horiki N, Iwasa M, Takei Y. Extracellular vesicles from pancreatic ductal adenocarcinoma endoscopic ultrasound-fine needle aspiration samples contain a protein barcode. J Hepatobiliary Pancreat Sci 2021. [PMID: 34555251 DOI: 10.1002/jhbp.1048] [Reference Citation Analysis]
62 Rivelsrud M, Paur I, Sygnestveit K, Nilsen RM, Tangvik RJ. Nutritional treatment is associated with longer survival in patients with pancreatic disease and concomitant risk of malnutrition. Clin Nutr 2021;40:2128-37. [PMID: 33059912 DOI: 10.1016/j.clnu.2020.09.037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Kim A, Ha J, Kim J, Cho Y, Ahn J, Cheon C, Kim SH, Ko SG, Kim B. Natural Products for Pancreatic Cancer Treatment: From Traditional Medicine to Modern Drug Discovery. Nutrients 2021;13:3801. [PMID: 34836055 DOI: 10.3390/nu13113801] [Reference Citation Analysis]
64 Geismann C, Arlt A. Coming in the Air: Hypoxia Meets Epigenetics in Pancreatic Cancer. Cells 2020;9:E2353. [PMID: 33113836 DOI: 10.3390/cells9112353] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
65 Mukherjee M, Goswami S. Identification of Key Deregulated RNA-Binding Proteins in Pancreatic Cancer by Meta-Analysis and Prediction of Their Role as Modulators of Oncogenesis. Front Cell Dev Biol 2021;9:713852. [PMID: 34912796 DOI: 10.3389/fcell.2021.713852] [Reference Citation Analysis]
66 Efthymiou M, Chandran S, Zorron Cheng Tao Pu L, Collins A, Rajadurai A, Nikfarjam M, Vaughan R. Outcomes of endoscopic ultrasound as a one-off pancreatic cancer screening tool for 122 high- and moderate-risk patients. JGH Open 2020;4:1217-23. [PMID: 33319059 DOI: 10.1002/jgh3.12432] [Reference Citation Analysis]
67 Timmer FEF, Geboers B, Nieuwenhuizen S, Schouten EAC, Dijkstra M, de Vries JJJ, van den Tol MP, Meijerink MR, Scheffer HJ. Locoregional Treatment of Metastatic Pancreatic Cancer Utilizing Resection, Ablation and Embolization: A Systematic Review. Cancers (Basel) 2021;13:1608. [PMID: 33807220 DOI: 10.3390/cancers13071608] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
68 Loftis AR, Santos MS, Truex NL, Biancucci M, Satchell KJF, Pentelute BL. Anthrax Protective Antigen Retargeted with Single-Chain Variable Fragments Delivers Enzymes to Pancreatic Cancer Cells. Chembiochem 2020;21:2772-6. [PMID: 32369652 DOI: 10.1002/cbic.202000201] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
69 Fru PN, Nweke EE, Mthimkhulu N, Mvango S, Nel M, Pilcher LA, Balogun M. Anti-Cancer and Immunomodulatory Activity of a Polyethylene Glycol-Betulinic Acid Conjugate on Pancreatic Cancer Cells. Life (Basel) 2021;11:462. [PMID: 34063891 DOI: 10.3390/life11060462] [Reference Citation Analysis]
70 Dzobo K, Ganz C, Thomford NE, Senthebane DA. Cancer Stem Cell Markers in Relation to Patient Survival Outcomes: Lessons for Integrative Diagnostics and Next-Generation Anticancer Drug Development. OMICS 2021;25:81-92. [PMID: 33170084 DOI: 10.1089/omi.2020.0185] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
71 Luo D, Xu X, Iqbal MZ, Zhao Q, Zhao R, Farheen J, Zhang Q, Zhang P, Kong X. siRNA-Loaded Hydroxyapatite Nanoparticles for KRAS Gene Silencing in Anti-Pancreatic Cancer Therapy. Pharmaceutics 2021;13:1428. [PMID: 34575504 DOI: 10.3390/pharmaceutics13091428] [Reference Citation Analysis]
72 Qiao PL, Gargesha M, Liu Y, Laney VEA, Hall RC, Vaidya AM, Gilmore H, Gawelek K, Scott BB, Roy D, Wilson DL, Lu ZR. Magnetic resonance molecular imaging of extradomain B fibronectin enables detection of pancreatic ductal adenocarcinoma metastasis. Magn Reson Imaging 2022;86:37-45. [PMID: 34801672 DOI: 10.1016/j.mri.2021.11.008] [Reference Citation Analysis]
73 Zhuang H, Wang S, Chen B, Zhang Z, Ma Z, Li Z, Liu C, Zhou Z, Gong Y, Huang S, Hou B, Chen Y, Zhang C. Prognostic Stratification Based on HIF-1 Signaling for Evaluating Hypoxic Status and Immune Infiltration in Pancreatic Ductal Adenocarcinomas. Front Immunol 2021;12:790661. [PMID: 34925373 DOI: 10.3389/fimmu.2021.790661] [Reference Citation Analysis]
74 Silke J, O'Reilly LA. NF-κB and Pancreatic Cancer; Chapter and Verse. Cancers (Basel) 2021;13:4510. [PMID: 34572737 DOI: 10.3390/cancers13184510] [Reference Citation Analysis]
75 Moccia M, Caratelli V, Cinti S, Pede B, Avitabile C, Saviano M, Imbriani AL, Moscone D, Arduini F. Paper-based electrochemical peptide nucleic acid (PNA) biosensor for detection of miRNA-492: a pancreatic ductal adenocarcinoma biomarker. Biosens Bioelectron 2020;165:112371. [PMID: 32729503 DOI: 10.1016/j.bios.2020.112371] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
76 Huo H, Jiang W, Sun F, Li J, Shi B. Synthesis and biological evaluation of novel steroidal pyrazole amides as highly potent anticancer agents. Steroids 2021;176:108931. [PMID: 34655595 DOI: 10.1016/j.steroids.2021.108931] [Reference Citation Analysis]
77 Perlmutter BC, Hossain MS, Naples R, Tu C, Vilchez V, McMichael J, Tullio K, Simon R, Walsh RM, Augustin T. Survival impact based on hepatic artery lymph node status in pancreatic adenocarcinoma: A study of patients receiving modern chemotherapy. J Surg Oncol 2021;123:399-406. [PMID: 33159317 DOI: 10.1002/jso.26281] [Reference Citation Analysis]
78 Hetland G, Tangen JM, Mahmood F, Mirlashari MR, Nissen-Meyer LSH, Nentwich I, Therkelsen SP, Tjønnfjord GE, Johnson E. Antitumor, Anti-Inflammatory and Antiallergic Effects of Agaricus blazei Mushroom Extract and the Related Medicinal Basidiomycetes Mushrooms, Hericium erinaceus and Grifola frondosa: A Review of Preclinical and Clinical Studies. Nutrients 2020;12:E1339. [PMID: 32397163 DOI: 10.3390/nu12051339] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
79 Stasiewicz M, Kwaśniewski M, Karpiński TM. Microbial Associations with Pancreatic Cancer: A New Frontier in Biomarkers. Cancers (Basel) 2021;13:3784. [PMID: 34359685 DOI: 10.3390/cancers13153784] [Reference Citation Analysis]
80 Herranz Pérez R, de la Morena López F, Majano Rodríguez PL, Molina Jiménez F, Vega Piris L, Santander Vaquero C. Molecular analysis of pancreatic cystic neoplasm in routine clinical practice. World J Gastrointest Endosc 2021; 13(2): 56-71 [PMID: 33623640 DOI: 10.4253/wjge.v13.i2.56] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Dulskas A, Patasius A, Linkeviciute-Ulinskiene D, Zabuliene L, Smailyte G. Cohort Study of Antihyperglycemic Medication and Pancreatic Cancer Patients Survival. Int J Environ Res Public Health 2020;17:E6016. [PMID: 32824907 DOI: 10.3390/ijerph17176016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
82 Zhu B, Wu X, Guo T, Guan N, Liu Y. Epidemiological Characteristics of Pancreatic Cancer in China From 1990 to 2019. Cancer Control 2021;28:10732748211051536. [PMID: 34713730 DOI: 10.1177/10732748211051536] [Reference Citation Analysis]
83 Manrai M, Tilak TVSVGK, Dawra S, Srivastava S, Singh A. Current and emerging therapeutic strategies in pancreatic cancer: Challenges and opportunities. World J Gastroenterol 2021; 27(39): 6572-6589 [PMID: 34754153 DOI: 10.3748/wjg.v27.i39.6572] [Reference Citation Analysis]
84 Al-Awwad N, Allehdan S, Al-Jaberi T, Hushki A, Albtoush Y, Bani-Hani K, Tayyem RF. Dietary and Lifestyle Factors Associated with Gastric and Pancreatic Cancers: A Case-Control Study. Prev Nutr Food Sci 2021;26:30-9. [PMID: 33859957 DOI: 10.3746/pnf.2021.26.1.30] [Reference Citation Analysis]
85 Tumas J, Tumiene B, Jurkeviciene J, Jasiunas E, Sileikis A. Nutritional and immune impairments and their effects on outcomes in early pancreatic cancer patients undergoing pancreatoduodenectomy. Clinical Nutrition 2020;39:3385-94. [DOI: 10.1016/j.clnu.2020.02.029] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
86 Heckl SM, Mau F, Senftleben A, Daunke T, Beckinger S, Abdullazade S, Schreiber S, Röcken C, Sebens S, Schäfer H. Programmed Death-Ligand 1 (PD-L1) Expression Is Induced by Insulin in Pancreatic Ductal Adenocarcinoma Cells Pointing to Its Role in Immune Checkpoint Control. Med Sci (Basel) 2021;9:48. [PMID: 34202040 DOI: 10.3390/medsci9030048] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
87 Jhaveri KS, Babaei Jandaghi A, Thipphavong S, Espin-Garcia O, Dodd A, Hutchinson S, Reichman TW, Moulton CA, McGilvary ID, Gallinger S. Can preoperative liver MRI with gadoxetic acid help reduce open-close laparotomies for curative intent pancreatic cancer surgery? Cancer Imaging 2021;21:45. [PMID: 34193282 DOI: 10.1186/s40644-021-00416-4] [Reference Citation Analysis]
88 Xu Y, Wang Y, Höti N, Clark DJ, Chen SY, Zhang H. The next "sweet" spot for pancreatic ductal adenocarcinoma: Glycoprotein for early detection. Mass Spectrom Rev 2021;:e21748. [PMID: 34766650 DOI: 10.1002/mas.21748] [Reference Citation Analysis]
89 Murakawa Y, Ootsuka K, Abue M. The Appropriate First-Line Chemotherapy Regimen for Incurable Pancreatic Cancer in Clinical Practice: A Consideration of Patients' Overall Survival and Quality of Life. J Pancreat Cancer 2021;7:48-56. [PMID: 34901695 DOI: 10.1089/pancan.2021.0005] [Reference Citation Analysis]
90 Pan CH, Otsuka Y, Sridharan B, Woo M, Leiton CV, Babu S, Torrente Gonçalves M, Kawalerski RR, K Bai JD, Chang DK, Biankin AV, Scampavia L, Spicer T, Escobar-Hoyos LF, Shroyer KR. An unbiased high-throughput drug screen reveals a potential therapeutic vulnerability in the most lethal molecular subtype of pancreatic cancer. Mol Oncol 2020;14:1800-16. [PMID: 32533886 DOI: 10.1002/1878-0261.12743] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
91 Haller SD, Monaco ML, Essani K. The Present Status of Immuno-Oncolytic Viruses in the Treatment of Pancreatic Cancer. Viruses. 2020;12. [PMID: 33213031 DOI: 10.3390/v12111318] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
92 Ma F, Wang H, Liu K, Wang Z, Chen S. CSN6 inhibition suppresses pancreatic adenocarcinoma metastasis via destabilizing the c-Fos protein. Exp Cell Res 2020;391:112004. [PMID: 32289284 DOI: 10.1016/j.yexcr.2020.112004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
93 Wan BS, Cheng M, Zhang L. Insulin-like growth factor 2 mRNA-binding protein 1 promotes cell proliferation via activation of AKT and is directly targeted by microRNA-494 in pancreatic cancer. World J Gastroenterol 2019; 25(40): 6063-6076 [PMID: 31686763 DOI: 10.3748/wjg.v25.i40.6063] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
94 Wang W, He Y, Wu L, Ye L, Yao L, Tang Z. Efficacy of extended versus standard lymphadenectomy in pancreatoduodenectomy for pancreatic head adenocarcinoma. An update meta-analysis. Pancreatology 2019;19:1074-80. [PMID: 31668841 DOI: 10.1016/j.pan.2019.10.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
95 Xie D, Qian B, Yang J, Peng X, Li Y, Hu T, Lu S, Chen X, Han Y. Can Elderly Patients With Pancreatic Cancer Gain Survival Advantages Through More Radical Surgeries? A SEER-Based Analysis. Front Oncol 2020;10:598048. [PMID: 33194764 DOI: 10.3389/fonc.2020.598048] [Reference Citation Analysis]
96 Rashid K, Röder C, Goumas F, Egberts JH, Kalthoff H. CD95L Inhibition Impacts Gemcitabine-Mediated Effects and Non-Apoptotic Signaling of TNF-α and TRAIL in Pancreatic Tumor Cells. Cancers (Basel) 2021;13:5458. [PMID: 34771621 DOI: 10.3390/cancers13215458] [Reference Citation Analysis]
97 Korpela T, Udd M, Mustonen H, Ristimäki A, Haglund C, Seppänen H, Kylänpää L. Association between chronic pancreatitis and pancreatic cancer: A 10-year retrospective study of endoscopically treated and surgical patients. Int J Cancer 2020;147:1450-60. [PMID: 32162688 DOI: 10.1002/ijc.32971] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
98 Oliveira C, Calmeiro J, Carrascal MA, Falcão A, Gomes C, Miguel Neves B, Teresa Cruz M. Exosomes as new therapeutic vectors for pancreatic cancer treatment. Eur J Pharm Biopharm 2021;161:4-14. [PMID: 33561524 DOI: 10.1016/j.ejpb.2021.02.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Buscail E, Alix-Panabières C, Quincy P, Cauvin T, Chauvet A, Degrandi O, Caumont C, Verdon S, Lamrissi I, Moranvillier I, Buscail C, Marty M, Laurent C, Vendrely V, Moreau-Gaudry F, Bedel A, Dabernat S, Chiche L. High Clinical Value of Liquid Biopsy to Detect Circulating Tumor Cells and Tumor Exosomes in Pancreatic Ductal Adenocarcinoma Patients Eligible for Up-Front Surgery. Cancers (Basel) 2019;11:E1656. [PMID: 31717747 DOI: 10.3390/cancers11111656] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 11.0] [Reference Citation Analysis]
100 Zu F, Liu P, Wang H, Zhu T, Sun J, Sheng W, Tan X. Integrated analysis identifies a pathway-related competing endogenous RNA network in the progression of pancreatic cancer. BMC Cancer 2020;20:958. [PMID: 33008376 DOI: 10.1186/s12885-020-07470-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
101 Partelli S, Sclafani F, Barbu ST, Beishon M, Bonomo P, Braz G, de Braud F, Brunner T, Cavestro GM, Crul M, Trill MD, Ferollà P, Herrmann K, Karamitopoulou E, Neuzillet C, Orsi F, Seppänen H, Torchio M, Valenti D, Zamboni G, Zins M, Costa A, Poortmans P. European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Pancreatic Cancer. Cancer Treat Rev 2021;99:102208. [PMID: 34238640 DOI: 10.1016/j.ctrv.2021.102208] [Reference Citation Analysis]
102 Gajate C, Gayet O, Fraunhoffer NA, Iovanna J, Dusetti N, Mollinedo F. Induction of Apoptosis in Human Pancreatic Cancer Stem Cells by the Endoplasmic Reticulum-Targeted Alkylphospholipid Analog Edelfosine and Potentiation by Autophagy Inhibition. Cancers (Basel) 2021;13:6124. [PMID: 34885233 DOI: 10.3390/cancers13236124] [Reference Citation Analysis]
103 Furini S, Falciani C. Expression and Role of Heparan Sulfated Proteoglycans in Pancreatic Cancer. Front Oncol 2021;11:695858. [PMID: 34249755 DOI: 10.3389/fonc.2021.695858] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Lei S, Zeng Z, He Z, Cao W. miRNA‑7515 suppresses pancreatic cancer cell proliferation, migration and invasion via downregulating IGF‑1 expression. Oncol Rep 2021;46:200. [PMID: 34296285 DOI: 10.3892/or.2021.8151] [Reference Citation Analysis]
105 Zhuang H, Zhou Z, Zhang Z, Chen X, Ma Z, Huang S, Gong Y, Zhang C, Hou B. B3GNT3 overexpression promotes tumor progression and inhibits infiltration of CD8+ T cells in pancreatic cancer. Aging (Albany NY) 2020;13:2310-29. [PMID: 33316775 DOI: 10.18632/aging.202255] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
106 Ren H, Wu CR, Qiu GT, Zhang LP, Aimaiti S, Wang CF. Equipping the American Joint Committee on Cancer Staging for Resectable Pancreatic Ductal Adenocarcinoma with Tumor Grade: A Novel Staging System. J Oncol 2020;2020:9093729. [PMID: 33014058 DOI: 10.1155/2020/9093729] [Reference Citation Analysis]
107 Wiest NE, Moktan VP, Oman SP, Chirilă RM. Screening for pancreatic cancer: a review for general clinicians. Rom J Intern Med 2020;58:119-28. [PMID: 32364522 DOI: 10.2478/rjim-2020-0009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Elsalem L, Jum'ah AA, Alfaqih MA, Aloudat O. The Bacterial Microbiota of Gastrointestinal Cancers: Role in Cancer Pathogenesis and Therapeutic Perspectives. Clin Exp Gastroenterol 2020;13:151-85. [PMID: 32440192 DOI: 10.2147/CEG.S243337] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
109 Schlick K, Kiem D, Greil R. Recent Advances in Pancreatic Cancer: Novel Prognostic Biomarkers and Targeted Therapy-A Review of the Literature. Biomolecules 2021;11:1469. [PMID: 34680101 DOI: 10.3390/biom11101469] [Reference Citation Analysis]
110 Basile D, Corvaja C, Caccialanza R, Aprile G. Sarcopenia: looking to muscle mass to better manage pancreatic cancer patients. Curr Opin Support Palliat Care 2019;13:279-85. [PMID: 31361630 DOI: 10.1097/SPC.0000000000000455] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
111 Etman SM, Abdallah OY, Mehanna RA, Elnaggar YSR. Lactoferrin/Hyaluronic acid double-coated lignosulfonate nanoparticles of quinacrine as a controlled release biodegradable nanomedicine targeting pancreatic cancer. Int J Pharm 2020;578:119097. [PMID: 32032904 DOI: 10.1016/j.ijpharm.2020.119097] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
112 Mundry CS, Eberle KC, Singh PK, Hollingsworth MA, Mehla K. Local and systemic immunosuppression in pancreatic cancer: Targeting the stalwarts in tumor's arsenal. Biochim Biophys Acta Rev Cancer 2020;1874:188387. [PMID: 32579889 DOI: 10.1016/j.bbcan.2020.188387] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
113 Han D, Gao F, Liu JL, Wang H, Fu Q, Yang GW. Analysis of radiotherapy impact on survival in resected stage I/II pancreatic cancer patients: a population-based study. BMC Cancer 2021;21:560. [PMID: 34001035 DOI: 10.1186/s12885-021-08288-4] [Reference Citation Analysis]
114 Kpossou AR, Gbessi DG, Gnangnon FHR, Ba Boukari MM, Vignon RK, Sokpon CNDM, Sehonou J. [Cancers of the pancreas at the National Hospital and University Center of Cotonou: epidemiological, diagnostic, therapeutic and prognostic features]. Pan Afr Med J 2021;39:18. [PMID: 34394809 DOI: 10.11604/pamj.2021.39.18.26261] [Reference Citation Analysis]
115 Zhang P, Tao W, Lu C, Fan L, Jiang Q, Yang C, Shang E, Cheng H, Che C, Duan J, Zhao M. Bruceine A induces cell growth inhibition and apoptosis through PFKFB4/GSK3β signaling in pancreatic cancer. Pharmacol Res 2021;169:105658. [PMID: 33992797 DOI: 10.1016/j.phrs.2021.105658] [Reference Citation Analysis]
116 Andersson G, Lundgren S, Heby M, Nodin B, Elebro J, Jirström K. Clinical significance of stromal ER and PR expression in periampullary adenocarcinoma. Biomark Res 2019;7:26. [PMID: 31827798 DOI: 10.1186/s40364-019-0176-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
117 Luo, Kuang F, Du J, Zhou M, Peng F, Gan Y, Fang C, Yang X, Li B, Su S. Characterization of the Immune Cell Infiltration Profile in Pancreatic Carcinoma to Aid in Immunotherapy. Front Oncol 2021;11:677609. [PMID: 34055645 DOI: 10.3389/fonc.2021.677609] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
118 Hull A, Li Y, Bartholomeusz D, Hsieh W, Allen B, Bezak E. Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma: A Review of the Current Status of Literature. Cancers (Basel) 2020;12:E481. [PMID: 32092952 DOI: 10.3390/cancers12020481] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
119 Principe DR, Narbutis M, Kumar S, Park A, Viswakarma N, Dorman MJ, Kamath SD, Grippo PJ, Fishel ML, Hwang RF, Thummuri D, Underwood PW, Munshi HG, Trevino JG, Rana A. Long-Term Gemcitabine Treatment Reshapes the Pancreatic Tumor Microenvironment and Sensitizes Murine Carcinoma to Combination Immunotherapy. Cancer Res 2020;80:3101-15. [PMID: 32238357 DOI: 10.1158/0008-5472.CAN-19-2959] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
120 Tan J, Liu W, Li J, Zhang X, Liu Y, Yuan Y, Song Z. Over-expressed RHEB promotes the progression of pancreatic adenocarcinoma. Life Sci 2021;277:119462. [PMID: 33831427 DOI: 10.1016/j.lfs.2021.119462] [Reference Citation Analysis]
121 Wang C, Yin W, Liu H. MicroRNA-10a promotes epithelial-to-mesenchymal transition and stemness maintenance of pancreatic cancer stem cells via upregulating the Hippo signaling pathway through WWC2 inhibition. J Cell Biochem 2020;121:4505-21. [PMID: 32542845 DOI: 10.1002/jcb.29716] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
122 Sipra QUAR, Islam M, Riaz IB, Zhaohui J, Babiker HM, Bekaii-Saab TS, Sonbol MB. Contemporary Management of Pancreatic Cancer from an Internist Perspective. Am J Med 2021;134:576-86. [PMID: 33316248 DOI: 10.1016/j.amjmed.2020.11.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
123 Murphy DP, Kanwar MA, Stell MD, Briggs MC, Bowles MM, Aroori MS. The prevalence of micronutrient deficiency in patients with suspected pancreatico-biliary malignancy: Results from a specialist Hepato-Biliary and Pancreatic unit. Eur J Surg Oncol 2021;47:1750-5. [PMID: 33775486 DOI: 10.1016/j.ejso.2021.03.227] [Reference Citation Analysis]
124 Huang C, Iovanna J, Santofimia-Castaño P. Targeting Fibrosis: The Bridge That Connects Pancreatitis and Pancreatic Cancer. Int J Mol Sci 2021;22:4970. [PMID: 34067040 DOI: 10.3390/ijms22094970] [Reference Citation Analysis]
125 Gnanamony M, Demirkhanyan L, Ge L, Sojitra P, Bapana S, Norton JA, Gondi CS. Circular dumbbell miR-34a-3p and -5p suppresses pancreatic tumor cell-induced angiogenesis and activates macrophages. Oncol Lett 2021;21:75. [PMID: 33365086 DOI: 10.3892/ol.2020.12336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
126 Starzyńska T, Karczmarski J, Paziewska A, Kulecka M, Kuśnierz K, Żeber-Lubecka N, Ambrożkiewicz F, Mikula M, Kos-Kudła B, Ostrowski J. Differences between Well-Differentiated Neuroendocrine Tumors and Ductal Adenocarcinomas of the Pancreas Assessed by Multi-Omics Profiling. Int J Mol Sci 2020;21:E4470. [PMID: 32586046 DOI: 10.3390/ijms21124470] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
127 Shi Y, Wang Y, Qian J, Yan X, Han Y, Yao N, Ma J. MGMT expression affects the gemcitabine resistance of pancreatic cancer cells. Life Sci 2020;259:118148. [PMID: 32721465 DOI: 10.1016/j.lfs.2020.118148] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
128 Ekanayake LS, Jenkins D, Swade S, Patel HP, Bruce D. Locally Invasive Pancreatic Adenocarcinoma Presenting in the Splenic Flexure: A Rare Case Report. Cureus 2020;12:e8085. [PMID: 32542140 DOI: 10.7759/cureus.8085] [Reference Citation Analysis]
129 Wei X, Mei C, Li X, Xie Y. The Unique Microbiome and Immunity in Pancreatic Cancer. Pancreas 2021;50:119-29. [DOI: 10.1097/mpa.0000000000001744] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
130 Narendra A, Baade PD, Aitken JF, Fawcett J, Smithers BM. Pancreaticoduodenectomy in a low-resection volume region: a population-level study examining the impact of hospital-volume on surgical quality and longer-term survival. HPB 2020;22:1288-94. [DOI: 10.1016/j.hpb.2019.11.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
131 Wang H, Yu S, Peng H, Shu Y, Zhang W, Zhu Q, Wu Y, Xu Y, Yan J, Xiang H. Long noncoding RNA Linc00337 functions as an E2F1 co-activator and promotes cell proliferation in pancreatic ductal adenocarcinoma. J Exp Clin Cancer Res 2020;39:216. [PMID: 33054826 DOI: 10.1186/s13046-020-01725-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
132 Mascitti M, Togni L, Troiano G, Caponio VCA, Gissi DB, Montebugnoli L, Procaccini M, Lo Muzio L, Santarelli A. Beyond Head and Neck Cancer: The Relationship Between Oral Microbiota and Tumour Development in Distant Organs. Front Cell Infect Microbiol 2019;9:232. [PMID: 31297343 DOI: 10.3389/fcimb.2019.00232] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 10.0] [Reference Citation Analysis]
133 Moraa F, Degu A. Survival Outcomes Among Pancreatic Cancer Patients at Kenyatta National Hospital. J Gastrointest Cancer 2021. [PMID: 34601708 DOI: 10.1007/s12029-021-00723-w] [Reference Citation Analysis]
134 Bradley SD, Talukder AH, Lai I, Davis R, Alvarez H, Tiriac H, Zhang M, Chiu Y, Melendez B, Jackson KR, Katailiha A, Sonnemann HM, Li F, Kang Y, Qiao N, Pan BF, Lorenzi PL, Hurd M, Mittendorf EA, Peterson CB, Javle M, Bristow C, Kim M, Tuveson DA, Hawke D, Kopetz S, Wolff RA, Hwu P, Maitra A, Roszik J, Yee C, Lizée G. Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancers. Nat Commun 2020;11:5332. [PMID: 33087697 DOI: 10.1038/s41467-020-19141-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
135 Jiang J, Xu Y, Chang L, Ru G, Xia X, Yang L, Yi X, Chen Z, Huang DS, Yang L. Genomic Landscape in Neoplasm-Like Stroma Reveals Distinct Prognostic Subtypes of Pancreatic Ductal Adenocarcinoma. Front Oncol 2021;11:771247. [PMID: 34733795 DOI: 10.3389/fonc.2021.771247] [Reference Citation Analysis]
136 van Dam MA, Vuijk FA, Stibbe JA, Houvast RD, Luelmo SAC, Crobach S, Shahbazi Feshtali S, de Geus-Oei LF, Bonsing BA, Sier CFM, Kuppen PJK, Swijnenburg RJ, Windhorst AD, Burggraaf J, Vahrmeijer AL, Mieog JSD. Overview and Future Perspectives on Tumor-Targeted Positron Emission Tomography and Fluorescence Imaging of Pancreatic Cancer in the Era of Neoadjuvant Therapy. Cancers (Basel) 2021;13:6088. [PMID: 34885196 DOI: 10.3390/cancers13236088] [Reference Citation Analysis]
137 Bruun-Sørensen AS, Edamana S, Login FH, Borgquist S, Nejsum LN. Aquaporins in pancreatic ductal adenocarcinoma. APMIS 2021;129:700-5. [PMID: 34582595 DOI: 10.1111/apm.13184] [Reference Citation Analysis]
138 GBD 2017 Pancreatic Cancer Collaborators. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2019;4:934-947. [PMID: 31648972 DOI: 10.1016/s2468-1253(19)30347-4] [Cited by in Crossref: 85] [Cited by in F6Publishing: 60] [Article Influence: 28.3] [Reference Citation Analysis]
139 Dehghanian F, Azhir Z, Khalilian S, Grüning B. Non-coding RNAs underlying the pathophysiological links between type 2 diabetes and pancreatic cancer: A systematic review. J Diabetes Investig 2021. [PMID: 34859606 DOI: 10.1111/jdi.13727] [Reference Citation Analysis]
140 Tsesmelis M, Tiwary K, Steiger K, Sperb N, Gerstenlauer M, Manfras U, Maier HJ, Hermann PC, Chan LK, Wirth T. Deletion of NEMO Inhibits EMT and Reduces Metastasis in KPC Mice. Cancers (Basel) 2021;13:4541. [PMID: 34572768 DOI: 10.3390/cancers13184541] [Reference Citation Analysis]
141 Senavirathna L, Ma C, Chen R, Pan S. Proteomic Investigation of Glyceraldehyde-Derived Intracellular AGEs and Their Potential Influence on Pancreatic Ductal Cells. Cells 2021;10:1005. [PMID: 33923186 DOI: 10.3390/cells10051005] [Reference Citation Analysis]
142 Takeda Y, Kobayashi S, Kitakaze M, Yamada D, Akita H, Asai A, Konno M, Arai T, Kitagawa T, Ofusa K, Yabumoto M, Hirotsu T, Vecchione A, Taniguchi M, Doki Y, Eguchi H, Ishii H. Immuno-Surgical Management of Pancreatic Cancer with Analysis of Cancer Exosomes. Cells 2020;9:E1645. [PMID: 32659892 DOI: 10.3390/cells9071645] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
143 Carter CJ, Mekkawy AH, Morris DL. Role of human nucleoside transporters in pancreatic cancer and chemoresistance. World J Gastroenterol 2021; 27(40): 6844-6860 [PMID: 34790010 DOI: 10.3748/wjg.v27.i40.6844] [Reference Citation Analysis]
144 Hou J, Wang Z, Li H, Zhang H, Luo L. Gene Signature and Identification of Clinical Trait-Related m6 A Regulators in Pancreatic Cancer. Front Genet 2020;11:522. [PMID: 32754191 DOI: 10.3389/fgene.2020.00522] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
145 Sato H, Liss AS, Mizukami Y. Large-duct pattern invasive adenocarcinoma of the pancreas–a variant mimicking pancreatic cystic neoplasms: A minireview. World J Gastroenterol 2021; 27(23): 3262-3278 [PMID: 34163110 DOI: 10.3748/wjg.v27.i23.3262] [Reference Citation Analysis]
146 Verloy R, Privat-Maldonado A, Smits E, Bogaerts A. Cold Atmospheric Plasma Treatment for Pancreatic Cancer-The Importance of Pancreatic Stellate Cells. Cancers (Basel) 2020;12:E2782. [PMID: 32998311 DOI: 10.3390/cancers12102782] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
147 Rogers JE, Mizrahi JD, Xiao L, Mohindroo C, Shroff RT, Wolff R, Varadhachary GR, Javle MM, Overman M, Fogelman DR, Raghav KPS, Pant S, McAllister F. Modified gemcitabine plus nab-paclitaxel regimen in advanced pancreatic ductal adenocarcinoma. Cancer Med 2020;9:5406-15. [PMID: 32519420 DOI: 10.1002/cam4.3229] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
148 Wu P, Wang X, Ma Y, Xu X, Liu W, Sheng Z, Chen M, Zhou R, Zhang K, Goodin S, Zheng X, Li D. (3E,5E)-3,5-Bis(pyridin-3-methylene)-tetrahydrothiopyran-4-one enhances the inhibitory effect of gemcitabine on pancreatic cancer cells. Bioorg Chem 2020;101:104022. [PMID: 32599367 DOI: 10.1016/j.bioorg.2020.104022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
149 Takakura K, Kawamura A, Torisu Y, Koido S, Yahagi N, Saruta M. The Clinical Potential of Oligonucleotide Therapeutics against Pancreatic Cancer. Int J Mol Sci 2019;20:E3331. [PMID: 31284594 DOI: 10.3390/ijms20133331] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
150 Sheikh M, Masoudi S, Bakhshandeh R, Moayyedkazemi A, Zamani F, Nikfam S, Mansouri M, Shishavan NG, Nikeghbalian S, Brennan P, Malekzadeh R, Pourshams A. Survival features, prognostic factors, and determinants of diagnosis and treatment among Iranian patients with pancreatic cancer, a prospective study. PLoS One 2020;15:e0243511. [PMID: 33275621 DOI: 10.1371/journal.pone.0243511] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
151 Panagiotou E, Gomatou G, Trontzas IP, Syrigos N, Kotteas E. Cyclin-dependent kinase (CDK) inhibitors in solid tumors: a review of clinical trials. Clin Transl Oncol 2021. [PMID: 34363593 DOI: 10.1007/s12094-021-02688-5] [Reference Citation Analysis]
152 Bushnell GG, Orbach SM, Ma JA, Crawford HC, Wicha MS, Jeruss JS, Shea LD. Disease-induced immunomodulation at biomaterial scaffolds detects early pancreatic cancer in a spontaneous model. Biomaterials 2021;269:120632. [PMID: 33418200 DOI: 10.1016/j.biomaterials.2020.120632] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
153 Anama-Green C, Quinn M. Survival Analysis of Demographic Factors Associated With 5+ Year Survival of Pancreatic Carcinoma. Cureus 2021;13:e13032. [PMID: 33665053 DOI: 10.7759/cureus.13032] [Reference Citation Analysis]
154 Demirtürk N, Bilensoy E. Nanocarriers targeting the diseases of the pancreas. Eur J Pharm Biopharm 2021:S0939-6411(21)00337-4. [PMID: 34852262 DOI: 10.1016/j.ejpb.2021.11.006] [Reference Citation Analysis]
155 Shi YQ, Zhou XC, Du P, Yin MY, Xu L, Chen WJ, Xu CF. Relationships are between metformin use and survival in pancreatic cancer patients concurrent with diabetes: A systematic review and meta-analysis. Medicine (Baltimore). 2020;99:e21687. [PMID: 32925714 DOI: 10.1097/md.0000000000021687] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
156 Huang J, Chen Z, Ding C, Lin S, Wan D, Ren K. Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma. Front Oncol 2021;11:711402. [PMID: 34497764 DOI: 10.3389/fonc.2021.711402] [Reference Citation Analysis]
157 Chen J, Yao D, Chen W, Li Z, Guo Y, Zhu F, Hu X. Serum exosomal miR-451a acts as a candidate marker for pancreatic cancer. Int J Biol Markers 2022;:17246008211070018. [PMID: 35001683 DOI: 10.1177/17246008211070018] [Reference Citation Analysis]
158 Ardalan B, Azqueta JI, England J, Eatz TA. Potential benefit of treatment with MEK inhibitors and chemotherapy in BRAF-mutated KRAS wild-type pancreatic ductal adenocarcinoma patients: a case report. Cold Spring Harb Mol Case Stud 2021;7:a006108. [PMID: 34667063 DOI: 10.1101/mcs.a006108] [Reference Citation Analysis]
159 Panebianco C, Pazienza V. Body site-dependent variations of microbiota in pancreatic cancer pathophysiology. Crit Rev Clin Lab Sci 2019;56:260-73. [PMID: 31060399 DOI: 10.1080/10408363.2019.1615407] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
160 Berardi R, Rinaldi S, Belfiori G, Partelli S, Crippa S, Torniai M, Falconi M. The Role of Hyponatraemia Before Surgery in Patients With Radical Resected Pancreatic Cancer. Clin Med Insights Oncol 2020;14:1179554920936605. [PMID: 32636693 DOI: 10.1177/1179554920936605] [Reference Citation Analysis]
161 Kong L, Liu P, Zheng M, Wang Z, Gao Y, Liang K, Wang H, Tan X. The miR-1224-5p/ELF3 Axis Regulates Malignant Behaviors of Pancreatic Cancer via PI3K/AKT/Notch Signaling Pathways. Onco Targets Ther 2020;13:3449-66. [PMID: 32368099 DOI: 10.2147/OTT.S248507] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
162 Panchal K, Sahoo RK, Gupta U, Chaurasiya A. Role of targeted immunotherapy for pancreatic ductal adenocarcinoma (PDAC) treatment: An overview. Int Immunopharmacol 2021;95:107508. [PMID: 33725635 DOI: 10.1016/j.intimp.2021.107508] [Reference Citation Analysis]
163 Fu XF, Zhao HC, Yang CL, Chen CZ, Wang K, Gao F, Tian YZ, Zhao HL. MicroRNA-203-3p inhibits the proliferation, invasion and migration of pancreatic cancer cells by downregulating fibroblast growth factor 2. Oncol Lett 2021;22:626. [PMID: 34267818 DOI: 10.3892/ol.2021.12887] [Reference Citation Analysis]
164 Zheng X, Liu X, Zheng H, Wang H, Hong D. Integrated bioinformatics analysis identified COL11A1 as an immune infiltrates correlated prognosticator in pancreatic adenocarcinoma. Int Immunopharmacol 2021;90:106982. [PMID: 33129696 DOI: 10.1016/j.intimp.2020.106982] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
165 Nissen NI, Kehlet S, Johansen AZ, Chen IM, Karsdal M, Johansen JS, Diab HMH, Jørgensen LN, Sun S, Manon-Jensen T, He Y, Langholm L, Willumsen N. Noninvasive prognostic biomarker potential of quantifying the propeptides of Type XI collagen alpha-1 chain (PRO-C11) in patients with pancreatic ductal adenocarcinoma. Int J Cancer 2021;149:228-38. [PMID: 33687786 DOI: 10.1002/ijc.33551] [Reference Citation Analysis]
166 Gilardini Montani MS, Cecere N, Granato M, Romeo MA, Falcinelli L, Ciciarelli U, D'Orazi G, Faggioni A, Cirone M. Mutant p53, Stabilized by Its Interplay with HSP90, Activates a Positive Feed-Back Loop Between NRF2 and p62 that Induces Chemo-Resistance to Apigenin in Pancreatic Cancer Cells. Cancers (Basel) 2019;11:E703. [PMID: 31121848 DOI: 10.3390/cancers11050703] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
167 Urman JM, Herranz JM, Uriarte I, Rullán M, Oyón D, González B, Fernandez-Urién I, Carrascosa J, Bolado F, Zabalza L, Arechederra M, Alvarez-Sola G, Colyn L, Latasa MU, Puchades-Carrasco L, Pineda-Lucena A, Iraburu MJ, Iruarrizaga-Lejarreta M, Alonso C, Sangro B, Purroy A, Gil I, Carmona L, Cubero FJ, Martínez-Chantar ML, Banales JM, Romero MR, Macias RIR, Monte MJ, Marín JJG, Vila JJ, Corrales FJ, Berasain C, Fernández-Barrena MG, Avila MA. Pilot Multi-Omic Analysis of Human Bile from Benign and Malignant Biliary Strictures: A Machine-Learning Approach. Cancers (Basel) 2020;12:E1644. [PMID: 32575903 DOI: 10.3390/cancers12061644] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
168 Li L, Zhang X, Liu N, Chen X, Peng C. LINC00473: A novel oncogenic long noncoding RNA in human cancers. J Cell Physiol 2021;236:4174-83. [PMID: 33222224 DOI: 10.1002/jcp.30176] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
169 Bannoura SF, Uddin MH, Nagasaka M, Fazili F, Al-Hallak MN, Philip PA, El-Rayes B, Azmi AS. Targeting KRAS in pancreatic cancer: new drugs on the horizon. Cancer Metastasis Rev 2021;40:819-35. [PMID: 34499267 DOI: 10.1007/s10555-021-09990-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
170 Wu D, Li X, Zhang X, Han F, Lu X, Liu L, Zhang J, Dong M, Yang H, Li H. Pharmacometabolomics Identifies 3-Hydroxyadipic Acid, d-Galactose, Lysophosphatidylcholine (P-16:0), and Tetradecenoyl-l-Carnitine as Potential Predictive Indicators of Gemcitabine Efficacy in Pancreatic Cancer Patients. Front Oncol 2019;9:1524. [PMID: 32064236 DOI: 10.3389/fonc.2019.01524] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
171 Fernández-Aceñero MJ, Barderas R, Peláez García A, Martínez-Useros J, Díez-Valladares L, Pérez-Aguirre, Ortega Medina L, de la Serna Esteban S, García-Botella S, Díaz Del Arco C, Galindo C. Aryl hydrocarbon receptor interacting protein (AIP) significantly influences prognosis of pancreatic carcinoma. Ann Diagn Pathol 2021;53:151742. [PMID: 33975263 DOI: 10.1016/j.anndiagpath.2021.151742] [Reference Citation Analysis]
172 Rosemurgy AS, Ross S, Luberice K, Browning H, Sucandy I. Robotic Pancreatic Surgery for Solid, Cystic, and Mixed Lesions. Surg Clin North Am 2020;100:303-36. [PMID: 32169182 DOI: 10.1016/j.suc.2019.12.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
173 Gupta N, Park JE, Tse W, Low JK, Kon OL, McCarthy N, Sze SK. ERO1α promotes hypoxic tumor progression and is associated with poor prognosis in pancreatic cancer. Oncotarget 2019;10:5970-82. [PMID: 31666928 DOI: 10.18632/oncotarget.27235] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
174 Zheng K, Guo X, Feng J, Bai Z, Shao X, Yi F, Zhang Y, Zhang R, Liu H, Romeiro FG, Qi X. Gastrointestinal Bleeding due to Pancreatic Disease-Related Portal Hypertension. Gastroenterol Res Pract 2020;2020:3825186. [PMID: 32308674 DOI: 10.1155/2020/3825186] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
175 Vera RE, Fernandez-Zapico ME. Stromal deactivation by CSF1: a new feature of the aggressive pancreatic cancer microenvironment. EMBO Rep 2020;21:e50468. [PMID: 32329185 DOI: 10.15252/embr.202050468] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
176 Viswakarma N, Sondarva G, Principe DR, Nair RS, Kumar S, Singh SK, Das S, Sinha SC, Grippo PJ, Grimaldo S, Giulianotti PC, Rana B, Rana A. Mixed Lineage Kinase 3 phosphorylates prolyl-isomerase PIN1 and potentiates GLI1 signaling in pancreatic cancer development. Cancer Lett 2021;515:1-13. [PMID: 34052323 DOI: 10.1016/j.canlet.2021.04.015] [Reference Citation Analysis]
177 Ariston Gabriel AN, Jiao Q, Yvette U, Yang X, Al-Ameri SA, Du L, Wang YS, Wang C. Differences between KC and KPC pancreatic ductal adenocarcinoma mice models, in terms of their modeling biology and their clinical relevance. Pancreatology 2020;20:79-88. [PMID: 31780287 DOI: 10.1016/j.pan.2019.11.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
178 Zheng H, Ding B, Xue K, Yu J, Lou W. Construction of a lncRNA/pseudogene-hsa-miR-30d-5p-GJA1 regulatory network related to metastasis of pancreatic cancer. Genomics 2021;113:1742-53. [PMID: 33839271 DOI: 10.1016/j.ygeno.2021.04.013] [Reference Citation Analysis]
179 Arafa A, Eshak ES, Abdel Rahman TA, Anwar MM. Hepatitis C virus infection and risk of pancreatic cancer: A meta-analysis. Cancer Epidemiol 2020;65:101691. [PMID: 32088651 DOI: 10.1016/j.canep.2020.101691] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
180 Ren Q, Wang J, Liu C, Meng LX, Qian RK, Gao HJ, Qin W, Zhou CJ, Qiao S, Wang HY, Zhang LT, Zhang YT. Exploring the sulfate patterns of chondroitin sulfate/dermatan sulfate and keratan sulfate in human pancreatic cancer. J Pharm Biomed Anal 2021;205:114339. [PMID: 34464868 DOI: 10.1016/j.jpba.2021.114339] [Reference Citation Analysis]
181 Limbu Y, Regmee S, Ghimire R, Maharjan DK, Thapa PB. Arterial Divestment and Resection in Post-neoadjuvant Pancreatic Adenocarcinoma. Cureus 2021;13:e20275. [PMID: 34912651 DOI: 10.7759/cureus.20275] [Reference Citation Analysis]
182 Zhou Q, Tao X, Xia S, Guo F, Pan C, Xiang H, Shang D. T Lymphocytes: A Promising Immunotherapeutic Target for Pancreatitis and Pancreatic Cancer? Front Oncol 2020;10:382. [PMID: 32266154 DOI: 10.3389/fonc.2020.00382] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
183 Liu X, Chen B, Chen J, Sun S. A novel tp53-associated nomogram to predict the overall survival in patients with pancreatic cancer. BMC Cancer 2021;21:335. [PMID: 33789615 DOI: 10.1186/s12885-021-08066-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
184 Ristau P, Oetting-Roß C, Büscher A. Coping in patients with pancreatic cancer: a scoping review and narrative synthesis. BMJ Support Palliat Care 2021:bmjspcare-2021-003266. [PMID: 34880064 DOI: 10.1136/bmjspcare-2021-003266] [Reference Citation Analysis]
185 Toledo PF, Berger Z, Carreño L, Cardenas G, Castillo J, Orellana O. Sarcomatoid carcinoma of the pancreas — a rare tumor with an uncommon presentation and course: A case report and review of literature. World J Clin Cases 2021; 9(15): 3716-3725 [PMID: 34046475 DOI: 10.12998/wjcc.v9.i15.3716] [Reference Citation Analysis]
186 Gardner KP, Aldakkak M, Tang CM, Tsai S, Adams DL. Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes. NPJ Precis Oncol 2021;5:25. [PMID: 33742084 DOI: 10.1038/s41698-021-00161-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
187 Jiang J, Liu R, Zhang Z, Zhang X, Qi R, Chen S, Zhang X, Xi Y, Guo Q, Zheng H, Hua B. Study on the treatment of pancreatic cancer with integrated traditional Chinese and Western medicine: A study protocol of a multicenter prospective cohort study. Medicine (Baltimore) 2019;98:e17975. [PMID: 31764804 DOI: 10.1097/MD.0000000000017975] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
188 Castillo Tuñón JM, Valle Rodas ME, Botello Martínez F, Rojas Holguín A, López Guerra D, Santos Naharro J, Jaén Torrejímeno I, Blanco Fernández G. Implementation of a regional reference center in pancreatic surgery. Experience after 631 procedures. Cir Esp (Engl Ed) 2021;99:745-56. [PMID: 34794902 DOI: 10.1016/j.cireng.2021.11.001] [Reference Citation Analysis]
189 Liang YY, Bacanu S, Sreekumar L, Ramos AD, Dai L, Michaelis M, Cinatl J, Seki T, Cao Y, Coffill CR, Lane DP, Prabhu N, Nordlund P. CETSA interaction proteomics define specific RNA-modification pathways as key components of fluorouracil-based cancer drug cytotoxicity. Cell Chem Biol 2021:S2451-9456(21)00306-8. [PMID: 34265272 DOI: 10.1016/j.chembiol.2021.06.007] [Reference Citation Analysis]
190 Thyagarajan A, Alshehri MSA, Miller KLR, Sherwin CM, Travers JB, Sahu RP. Myeloid-Derived Suppressor Cells and Pancreatic Cancer: Implications in Novel Therapeutic Approaches. Cancers (Basel) 2019;11:E1627. [PMID: 31652904 DOI: 10.3390/cancers11111627] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
191 Campbell DJ, Isch EL, Kozak GM, Yeo CJ. Primary Pancreatic Signet Ring Cell Carcinoma: A Case Report and Review of the Literature. J Pancreat Cancer 2021;7:1-7. [PMID: 33569523 DOI: 10.1089/pancan.2020.0013] [Reference Citation Analysis]
192 Park MY, Lee W, Kwon J, Song KB, Hwang DW, Lee JH, Kim SC. Comparison of perioperative outcomes in pancreatic head cancer patients following either a laparoscopic or open pancreaticoduodenectomy with a superior mesenteric artery first approach. Ann Hepatobiliary Pancreat Surg 2021;25:358-65. [PMID: 34402436 DOI: 10.14701/ahbps.2021.25.3.358] [Reference Citation Analysis]
193 Liang E, Lu Y, Shi Y, Zhou Q, Zhi F. MYEOV increases HES1 expression and promotes pancreatic cancer progression by enhancing SOX9 transactivity. Oncogene 2020;39:6437-50. [PMID: 32879444 DOI: 10.1038/s41388-020-01443-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
194 Arafa A, Eshak ES, Dong JY, Shirai K, Muraki I, Iso H, Tamakoshi A; JACC Study Group. Dairy intake and the risk of pancreatic cancer: the Japan Collaborative Cohort Study (JACC Study) and meta-analysis of prospective cohort studies. Br J Nutr 2021;:1-9. [PMID: 34666857 DOI: 10.1017/S0007114521004232] [Reference Citation Analysis]
195 Zhu H, Li Q, Zhao Y, Peng H, Guo L, Zhu J, Jiang Z, Zeng Z, Xu B, Chen S. Vaccinia-related kinase 2 drives pancreatic cancer progression by protecting Plk1 from Chfr-mediated degradation. Oncogene 2021;40:4663-74. [PMID: 34140642 DOI: 10.1038/s41388-021-01893-4] [Reference Citation Analysis]
196 Cao L, Wu J, Qu X, Sheng J, Cui M, Liu S, Huang X, Xiang Y, Li B, Zhang X, Cui R. Glycometabolic rearrangements--aerobic glycolysis in pancreatic cancer: causes, characteristics and clinical applications. J Exp Clin Cancer Res 2020;39:267. [PMID: 33256814 DOI: 10.1186/s13046-020-01765-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
197 Muggilli M, Russell D, Zhou Z. Comparison of programmed death ligand 1 immunostaining for pancreatic ductal adenocarcinoma between paired cytological and surgical samples. Cytojournal 2021;18:28. [PMID: 34876919 DOI: 10.25259/Cytojournal_78_2020] [Reference Citation Analysis]
198 Kang Y, Wang X, Wei X, Li D, Gan L, Jin J, Wu R, Wu P, Sheng Z, Zhang K, Goodin S, Xu X, Zheng X. Synergistic inhibitory effect of α-humulene and sclareol on human pancreatic cancer cells. Journal of Functional Foods 2022;89:104958. [DOI: 10.1016/j.jff.2022.104958] [Reference Citation Analysis]
199 Liu M, Wang M, Li S. Prognostic Factors of Survival in Pancreatic Cancer Metastasis to Liver at Different Ages of Diagnosis: A SEER Population-Based Cohort Study. Front Big Data 2021;4:654972. [PMID: 34651122 DOI: 10.3389/fdata.2021.654972] [Reference Citation Analysis]
200 Yu Q, Jobin C, Thomas RM. Implications of the microbiome in the development and treatment of pancreatic cancer: Thinking outside of the box by looking inside the gut. Neoplasia 2021;23:246-56. [PMID: 33418277 DOI: 10.1016/j.neo.2020.12.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
201 van Duijneveldt G, Griffin MDW, Putoczki TL. Emerging roles for the IL-6 family of cytokines in pancreatic cancer. Clin Sci (Lond) 2020;134:2091-115. [PMID: 32808663 DOI: 10.1042/CS20191211] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
202 Wen X, Shao Z, Chen S, Wang W, Wang Y, Jiang J, Ma Q, Zhang L. Construction of an RNA-Binding Protein-Related Prognostic Model for Pancreatic Adenocarcinoma Based on TCGA and GTEx Databases. Front Genet 2020;11:610350. [PMID: 33584809 DOI: 10.3389/fgene.2020.610350] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
203 Ishido K, Kimura N, Wakiya T, Nagase H, Hara Y, Kanda T, Fujita H, Hakamada K. Development of a Biomarker-Based Scoring System Predicting Early Recurrence of Resectable Pancreatic Duct Adenocarcinoma. Ann Surg Oncol 2021. [PMID: 34608555 DOI: 10.1245/s10434-021-10866-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
204 Estaras M, Gonzalez A. Modulation of cell physiology under hypoxia in pancreatic cancer. World J Gastroenterol 2021; 27(28): 4582-4602 [PMID: 34366624 DOI: 10.3748/wjg.v27.i28.4582] [Reference Citation Analysis]
205 Di Federico A, Tateo V, Parisi C, Formica F, Carloni R, Frega G, Rizzo A, Ricci D, Di Marco M, Palloni A, Brandi G. Hacking Pancreatic Cancer: Present and Future of Personalized Medicine. Pharmaceuticals (Basel) 2021;14:677. [PMID: 34358103 DOI: 10.3390/ph14070677] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
206 Wang AM, Qiu R, Zhang D, Zhao XY. Therapeutic effects of an innovative BS-HH-002 drug on pancreatic cancer cells via induction of complete MCL-1 degradation. Transl Oncol 2022;15:101288. [PMID: 34847421 DOI: 10.1016/j.tranon.2021.101288] [Reference Citation Analysis]
207 Lin CW, Wang YJ, Lai TY, Hsu TL, Han SY, Wu HC, Shen CN, Dang V, Chen MW, Chen LB, Wong CH. Homogeneous antibody and CAR-T cells with improved effector functions targeting SSEA-4 glycan on pancreatic cancer. Proc Natl Acad Sci U S A 2021;118:e2114774118. [PMID: 34876527 DOI: 10.1073/pnas.2114774118] [Reference Citation Analysis]
208 Zhang J, Zhang Z. Mechanisms of circular RNA circ_0066147 on pancreatic cancer progression. Open Life Sci 2021;16:495-510. [PMID: 34056113 DOI: 10.1515/biol-2021-0047] [Reference Citation Analysis]
209 Li H, Pan W, Xu L, Yin D, Cheng S, Zhao F. Prognostic Significance of Microvascular Invasion in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis. Med Sci Monit 2021;27:e930545. [PMID: 34393219 DOI: 10.12659/MSM.930545] [Reference Citation Analysis]
210 Forsythe S, Pu T, Skardal A. Using organoid models to predict chemotherapy efficacy: the future of precision oncology? Expert Review of Precision Medicine and Drug Development 2019;4:317-36. [DOI: 10.1080/23808993.2019.1685868] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
211 Guo D, Chen C, Lv S, Wu G, Shi W, Li H, Hu H. Management of Primary Squamous Cell Carcinoma of the Pancreas: A Case Report. Front Surg 2021;8:700229. [PMID: 34765634 DOI: 10.3389/fsurg.2021.700229] [Reference Citation Analysis]
212 Su D, Guo X, Huang L, Ye H, Li Z, Lin L, Chen R, Zhou Q. Tumor-neuroglia interaction promotes pancreatic cancer metastasis. Theranostics 2020;10:5029-47. [PMID: 32308766 DOI: 10.7150/thno.42440] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
213 Zhou Z, Ma Z, Li Z, Zhuang H, Liu C, Gong Y, Huang S, Zhang C, Hou B. CMTM3 Overexpression Predicts Poor Survival and Promotes Proliferation and Migration in Pancreatic Cancer. J Cancer 2021;12:5797-806. [PMID: 34475993 DOI: 10.7150/jca.57082] [Reference Citation Analysis]
214 Vitolo V, Cobianchi L, Brugnatelli S, Barcellini A, Peloso A, Facoetti A, Vanoli A, Delfanti S, Preda L, Molinelli S, Klersy C, Fossati P, Orecchia R, Valvo F. Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: a prospective, phase II, multicentre, single-arm study. BMC Cancer 2019;19:922. [PMID: 31521134 DOI: 10.1186/s12885-019-6108-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
215 Huang CT, Liang YJ. Anti-tumor effect of statin on pancreatic adenocarcinoma: From concept to precision medicine. World J Clin Cases 2021; 9(18): 4500-4505 [PMID: 34222418 DOI: 10.12998/wjcc.v9.i18.4500] [Reference Citation Analysis]
216 Buscail E, Chiche L, Laurent C, Vendrely V, Denost Q, Denis J, Thumerel M, Lacorte JM, Bedel A, Moreau-Gaudry F, Dabernat S, Alix-Panabières C. Tumor-proximal liquid biopsy to improve diagnostic and prognostic performances of circulating tumor cells. Mol Oncol 2019;13:1811-26. [PMID: 31216108 DOI: 10.1002/1878-0261.12534] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
217 Pekarek L, Fraile-Martinez O, Garcia-Montero C, Alvarez-Mon MA, Acero J, Ruiz-Llorente L, García-Honduvilla N, Albillos A, Buján J, Alvarez-Mon M, Guijarro LG, Ortega MA. Towards an updated view on the clinical management of pancreatic adenocarcinoma: Current and future perspectives. Oncol Lett 2021;22:809. [PMID: 34630716 DOI: 10.3892/ol.2021.13070] [Reference Citation Analysis]
218 Dyrla P, Lubas A, Gil J, Saracyn M, Gonciarz M. Dynamic Doppler Ultrasound Assessment of Tissue Perfusion Is a Better Tool than a Single Vessel Doppler Examination in Differentiating Malignant and Inflammatory Pancreatic Lesions. Diagnostics (Basel) 2021;11:2289. [PMID: 34943526 DOI: 10.3390/diagnostics11122289] [Reference Citation Analysis]
219 George B, Kent M, Surinach A, Lamarre N, Cockrum P. The Association of Real-World CA 19-9 Level Monitoring Patterns and Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma. Front Oncol 2021;11:754687. [PMID: 34671563 DOI: 10.3389/fonc.2021.754687] [Reference Citation Analysis]
220 He M, Martin M, Marin T, Chen Z, Gongol B. Endothelial mechanobiology. APL Bioeng 2020;4:010904. [PMID: 32095737 DOI: 10.1063/1.5129563] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
221 Feliu J, Jorge Fernández M, Macarulla T, Massuti B, Albero A, González González JF, Quintero-Aldana G, Delgado-Mingorance JI, Fernández Montes A, García Piernavieja C, Valladares-Ayerbes M, López Muñoz AM, Mondéjar Solís R, Vicente P, Casado Gonzalez E, González Cebrián I, López-Vivanco G. Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: the BIBABRAX study. Cancer Chemother Pharmacol 2021;87:543-53. [PMID: 33452559 DOI: 10.1007/s00280-020-04214-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
222 Ferreira RG, Narvaez LEM, Espíndola KMM, Rosario ACRS, Lima WGN, Monteiro MC. Can Nimesulide Nanoparticles Be a Therapeutic Strategy for the Inhibition of the KRAS/PTEN Signaling Pathway in Pancreatic Cancer? Front Oncol 2021;11:594917. [PMID: 34354940 DOI: 10.3389/fonc.2021.594917] [Reference Citation Analysis]
223 Hu L, Xu H, Wang X, Wu B, Chen F, Chen W, Gao Y, Zhong Z. The expression and clinical prognostic value of protein phosphatase 1 catalytic subunit beta in pancreatic cancer. Bioengineered 2021;12:2763-78. [PMID: 34125004 DOI: 10.1080/21655979.2021.1934243] [Reference Citation Analysis]
224 Hao Q, Gao L, Niu W, Chen L, Zhang P, Chen Z. POTEE stimulates the proliferation of pancreatic cancer by activating the PI3K/Akt/GSK-3β/β-catenin signaling. Biofactors 2020;46:685-92. [PMID: 32589786 DOI: 10.1002/biof.1640] [Reference Citation Analysis]
225 Dambuza IM, Brown GD. Fungi accelerate pancreatic cancer. Nature 2019;574:184-5. [PMID: 31591542 DOI: 10.1038/d41586-019-02892-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
226 Galanopoulos M, Doukatas A, Gkeros F, Viazis N, Liatsos C. Room for improvement in the treatment of pancreatic cancer: Novel opportunities from gene targeted therapy. World J Gastroenterol 2021; 27(24): 3568-3580 [PMID: 34239270 DOI: 10.3748/wjg.v27.i24.3568] [Reference Citation Analysis]
227 Carrato A, Cerezo L, Feliu J, Macarulla T, Martín-Pérez E, Vera R, Álvarez J, Botella-Carretero JI. Clinical nutrition as part of the treatment pathway of pancreatic cancer patients: an expert consensus. Clin Transl Oncol 2021. [PMID: 34363594 DOI: 10.1007/s12094-021-02674-x] [Reference Citation Analysis]
228 Xavier CPR, Castro I, Caires HR, Ferreira D, Cavadas B, Pereira L, Santos LL, Oliveira MJ, Vasconcelos MH. Chitinase 3-like-1 and fibronectin in the cargo of extracellular vesicles shed by human macrophages influence pancreatic cancer cellular response to gemcitabine. Cancer Lett 2021;501:210-23. [PMID: 33212158 DOI: 10.1016/j.canlet.2020.11.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
229 Yin F, Zhang Q, Dong Z, Hu J, Ma Z. LncRNA HOTTIP Participates in Cisplatin Resistance of Tumor Cells by Regulating miR-137 Expression in Pancreatic Cancer. Onco Targets Ther 2020;13:2689-99. [PMID: 32280243 DOI: 10.2147/OTT.S234924] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
230 Jentzsch V, Davis JAA, Djamgoz MBA. Pancreatic Cancer (PDAC): Introduction of Evidence-Based Complementary Measures into Integrative Clinical Management. Cancers (Basel) 2020;12:E3096. [PMID: 33114159 DOI: 10.3390/cancers12113096] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
231 Zhao L, Cao Y. PD-L1 Expression Level Displays a Positive Correlation with Immune Response in Pancreatic Cancer. Dis Markers 2020;2020:8843146. [PMID: 33062072 DOI: 10.1155/2020/8843146] [Reference Citation Analysis]
232 Turanli B, Yildirim E, Gulfidan G, Arga KY, Sinha R. Current State of "Omics" Biomarkers in Pancreatic Cancer. J Pers Med 2021;11:127. [PMID: 33672926 DOI: 10.3390/jpm11020127] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
233 Zhu B, Huo R, Zhi Q, Zhan M, Chen X, Hua ZC. Increased expression of zinc transporter ZIP4, ZIP11, ZnT1, and ZnT6 predicts poor prognosis in pancreatic cancer. J Trace Elem Med Biol 2021;65:126734. [PMID: 33631610 DOI: 10.1016/j.jtemb.2021.126734] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
234 Bi C, Wang G. LINC00472 suppressed by ZEB1 regulates the miR-23a-3p/FOXO3/BID axis to inhibit the progression of pancreatic cancer. J Cell Mol Med 2021. [PMID: 34363438 DOI: 10.1111/jcmm.16784] [Reference Citation Analysis]
235 Madnick D, Handorf E, Ortiz A, Sorice K, Nagappan L, Moccia M, Cheema K, Vijayvergia N, Dotan E, Lynch SM. Investigating disparities: the effect of social environment on pancreatic cancer survival in metastatic patients. J Gastrointest Oncol 2020;11:633-43. [PMID: 32953147 DOI: 10.21037/jgo-20-39] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
236 Zhang Z, Gu J, Yin M, Wang D, Ma C, Du J, Lin Z, Hu S, Wang X, Li Y, Tan G, Luo H, Wei G. Establishment and Investigation of a Multiple Gene Expression Signature to Predict Long-Term Survival in Pancreatic Cancer. Biomed Res Int 2020;2020:1570862. [PMID: 33015155 DOI: 10.1155/2020/1570862] [Reference Citation Analysis]
237 Marques HS, de Brito BB, da Silva FAF, Santos MLC, de Souza JCB, Correia TML, Lopes LW, Neres NSM, Dórea RSDM, Dantas ACS, Morbeck LLB, Lima IS, de Almeida AA, Dias MRJ, de Melo FF. Relationship between Th17 immune response and cancer. World J Clin Oncol 2021; 12(10): 845-867 [PMID: 34733609 DOI: 10.5306/wjco.v12.i10.845] [Reference Citation Analysis]
238 Cisneros-villanueva M, Hidalgo-pérez L, Rios-romero M, Cedro-tanda A, Ruiz-villavicencio CA, Page K, Hastings R, Fernandez-garcia D, Allsopp R, Fonseca-montaño MA, Jimenez-morales S, Padilla-palma V, Shaw JA, Hidalgo-miranda A. Cell-free DNA analysis in current cancer clinical trials: a review. Br J Cancer. [DOI: 10.1038/s41416-021-01696-0] [Reference Citation Analysis]
239 Harvey JB, Phan LH, Villarreal OE, Bowser JL. CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers. Front Immunol 2020;11:508. [PMID: 32351498 DOI: 10.3389/fimmu.2020.00508] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
240 Nie Y, Zhao Z, Chen M, Ma F, Fan Y, Kang Y, Kang B, Wang C. Anillin is a prognostic factor and is correlated with genovariation in pancreatic cancer based on databases analysis. Oncol Lett 2021;21:107. [PMID: 33376540 DOI: 10.3892/ol.2020.12368] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
241 Argentiero A, Calabrese A, Sciacovelli AM, Delcuratolo S, Solimando AG, Brunetti O. Complete Response of Synchronous Liver Metastasis in a Pancreatic Ductal Adenocarcinoma, When Surgery Could Represent a Therapeutic Option. Can J Gastroenterol Hepatol 2020;2020:8679751. [PMID: 33102398 DOI: 10.1155/2020/8679751] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
242 Farooqui W, Riemenschneider KA, Penninga L, Vyrdal CD, Hansen CP, Storkholm JH. The diagnostic value of C-reactive protein for predicting pancreatic fistula following pancreatoduodenectomy. Scand J Gastroenterol 2021;56:329-35. [PMID: 33427522 DOI: 10.1080/00365521.2020.1867895] [Reference Citation Analysis]
243 Ma C, Yang P, Li J, Bian Y, Wang L, Lu J. Pancreatic adenocarcinoma: variability in measurements of tumor size among computed tomography, magnetic resonance imaging, and pathologic specimens. Abdom Radiol 2020;45:782-8. [DOI: 10.1007/s00261-019-02125-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
244 Puckett DL, Alquraishi M, Alani D, Chahed S, Donohoe D, Voy B, Whelan J, Bettaieb A. Zyflamend induces apoptosis in pancreatic cancer cells via modulation of the JNK pathway. Cell Commun Signal 2020;18:126. [PMID: 32795297 DOI: 10.1186/s12964-020-00609-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
245 Biagioni A, Tavakol S, Ahmadirad N, Zahmatkeshan M, Magnelli L, Mandegary A, Samareh Fekri H, Asadi MH, Mohammadinejad R, Ahn KS. Small nucleolar RNA host genes promoting epithelial-mesenchymal transition lead cancer progression and metastasis. IUBMB Life 2021;73:825-42. [PMID: 33938625 DOI: 10.1002/iub.2501] [Reference Citation Analysis]
246 Dong YM, Sun HN, Sun DC, Deng MH, Peng YG, Zhu YY. Pancreatic cancer with synchronous liver and colon metastases: A case report. World J Clin Cases 2021; 9(33): 10265-10272 [PMID: 34904098 DOI: 10.12998/wjcc.v9.i33.10265] [Reference Citation Analysis]
247 Sanchez TR, Klu YAK, Genkinger JM, Lacey JV Jr, Chung NT, Navas-Acien A. Association between rice consumption and risk of cancer incidence in the California Teachers Study. Cancer Causes Control 2020;31:1129-40. [PMID: 32974796 DOI: 10.1007/s10552-020-01350-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
248 Mentella MC, Scaldaferri F, Ricci C, Gasbarrini A, Miggiano GAD. Cancer and Mediterranean Diet: A Review. Nutrients 2019;11:E2059. [PMID: 31480794 DOI: 10.3390/nu11092059] [Cited by in Crossref: 60] [Cited by in F6Publishing: 47] [Article Influence: 20.0] [Reference Citation Analysis]
249 Du J, Gu J, Deng J, Kong L, Guo Y, Jin C, Bao Y, Fu D, Li J. The Expression and Survival Significance of Glucose Transporter-1 in Pancreatic Cancer: Meta-Analysis, Bioinformatics Analysis and Retrospective Study. Cancer Invest 2021;:1-15. [PMID: 34229540 DOI: 10.1080/07357907.2021.1950755] [Reference Citation Analysis]
250 Miquel M, Zhang S, Pilarsky C. Pre-clinical Models of Metastasis in Pancreatic Cancer. Front Cell Dev Biol 2021;9:748631. [PMID: 34778259 DOI: 10.3389/fcell.2021.748631] [Reference Citation Analysis]
251 Tominaga N. Anti-Cancer Role and Therapeutic Potential of Extracellular Vesicles. Cancers (Basel) 2021;13:6303. [PMID: 34944923 DOI: 10.3390/cancers13246303] [Reference Citation Analysis]
252 Gao Y, Chen S, Sun J, Su S, Yang D, Xiang L, Meng X. Traditional Chinese medicine may be further explored as candidate drugs for pancreatic cancer: A review. Phytother Res 2021;35:603-28. [PMID: 32965773 DOI: 10.1002/ptr.6847] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
253 Nguyen HQ, Pham NTT, Hoang VT, Van HAT, Huynh C, Hoang DT. Diffuse Pancreatic Carcinoma with Hepatic Metastases. Case Rep Oncol Med 2020;2020:8815745. [PMID: 33194237 DOI: 10.1155/2020/8815745] [Reference Citation Analysis]
254 Almasri B, Ali A. Role of endoscopic ultrasound elastography in differential diagnosis of pancreatic solid masses. Qatar Med J 2021;2021:40. [PMID: 34604016 DOI: 10.5339/qmj.2021.40] [Reference Citation Analysis]
255 Paro A, Dalmacy D, Hyer JM, Ejaz A, Cloyd J, Dillhoff M, Tsung A, Tsilimigras DI, Pawlik TM. Patterns of health care utilization among Medicare beneficiaries diagnosed with pancreatic adenocarcinoma. Am J Surg 2021:S0002-9610(21)00619-X. [PMID: 34715987 DOI: 10.1016/j.amjsurg.2021.10.027] [Reference Citation Analysis]
256 Liu SL, Li S, Guo YT, Zhou YP, Zhang ZD, Lu Y. Establishment and application of an artificial intelligence diagnosis system for pancreatic cancer with a faster region-based convolutional neural network. Chin Med J (Engl). 2019;132:2795-2803. [PMID: 31856050 DOI: 10.1097/cm9.0000000000000544] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
257 Huang H, Li X, Yu L, Liu L, Zhu H, Cao W, Sun Z, Yu X. Wogonoside inhibits TNF receptor-associated factor 6 (TRAF6) mediated-tumor microenvironment and prognosis of pancreatic cancer. Ann Transl Med 2021;9:1460. [PMID: 34734012 DOI: 10.21037/atm-21-4164] [Reference Citation Analysis]
258 Arcovito G, Di Stefano I, Boldrini L, Manassero F, Durante J, Tognarelli A, Faviana P. Unusual Case of Pancreatic Adenocarcinoma with Bladder Metastasis. Medicina (Kaunas) 2020;56:E708. [PMID: 33352898 DOI: 10.3390/medicina56120708] [Reference Citation Analysis]
259 Zhou J, Qie S, Fang H, Xi J. MiR-487a-3p suppresses the malignant development of pancreatic cancer by targeting SMAD7. Exp Mol Pathol 2020;116:104489. [PMID: 32622014 DOI: 10.1016/j.yexmp.2020.104489] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
260 Deftereos I, Yeung JMC, Arslan J, Carter VM, Isenring E, Kiss N, On Behalf Of The Nourish Point Prevalence Study Group. Assessment of Nutritional Status and Nutrition Impact Symptoms in Patients Undergoing Resection for Upper Gastrointestinal Cancer: Results from the Multi-Centre NOURISH Point Prevalence Study. Nutrients 2021;13:3349. [PMID: 34684353 DOI: 10.3390/nu13103349] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
261 Wu Y, Zhang C, Jiang K, Werner J, Bazhin AV, D'Haese JG. The Role of Stellate Cells in Pancreatic Ductal Adenocarcinoma: Targeting Perspectives. Front Oncol 2020;10:621937. [PMID: 33520728 DOI: 10.3389/fonc.2020.621937] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
262 Abe K, Kitago M, Kitagawa Y, Hirasawa A. Hereditary pancreatic cancer. Int J Clin Oncol 2021;26:1784-92. [PMID: 34476650 DOI: 10.1007/s10147-021-02015-6] [Reference Citation Analysis]
263 Carvalho TMA, Di Molfetta D, Greco MR, Koltai T, Alfarouk KO, Reshkin SJ, Cardone RA. Tumor Microenvironment Features and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights into Targeting Physicochemical Barriers and Metabolism as Therapeutic Approaches. Cancers (Basel) 2021;13:6135. [PMID: 34885243 DOI: 10.3390/cancers13236135] [Reference Citation Analysis]
264 Roacho-Pérez JA, Garza-Treviño EN, Delgado-Gonzalez P, G-Buentello Z, Delgado-Gallegos JL, Chapa-Gonzalez C, Sánchez-Domínguez M, Sánchez-Domínguez CN, Islas JF. Target Nanoparticles against Pancreatic Cancer: Fewer Side Effects in Therapy. Life (Basel) 2021;11:1187. [PMID: 34833063 DOI: 10.3390/life11111187] [Reference Citation Analysis]
265 Elechalawar CK, Hossen MN, Shankarappa P, Peer CJ, Figg WD, Robertson JD, Bhattacharya R, Mukherjee P. Targeting Pancreatic Cancer Cells and Stellate Cells Using Designer Nanotherapeutics in vitro. Int J Nanomedicine 2020;15:991-1003. [PMID: 32103952 DOI: 10.2147/IJN.S234112] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
266 Dang C, Wang M, Qin T, Qin R. Clinical importance of preoperative red-cell volume distribution width as a prognostic marker in patients undergoing radical surgery for pancreatic cancer. Surg Today 2021. [PMID: 34524510 DOI: 10.1007/s00595-021-02374-7] [Reference Citation Analysis]
267 Younan G. Pancreas Solid Tumors. Surg Clin North Am 2020;100:565-80. [PMID: 32402301 DOI: 10.1016/j.suc.2020.02.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
268 Ramai D, Lai JK, Ofori E, Linn S, Reddy M. Evaluation and Management of Premalignant Conditions of the Esophagus: A Systematic Survey of International Guidelines. Journal of Clinical Gastroenterology 2019;53:627-34. [DOI: 10.1097/mcg.0000000000001247] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
269 Petrov MS. Post-pancreatitis diabetes mellitus and excess intra-pancreatic fat deposition as harbingers of pancreatic cancer. World J Gastroenterol 2021; 27(17): 1936-1942 [PMID: 34007131 DOI: 10.3748/wjg.v27.i17.1936] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
270 Kurita A, Mori Y, Someya Y, Kubo S, Azuma S, Iwano K, Ikeda S, Okumura R, Yazumi S. High signal intensity on diffusion-weighted magnetic resonance images is a useful finding for detecting early-stage pancreatic cancer. Abdom Radiol (NY) 2021. [PMID: 34223962 DOI: 10.1007/s00261-021-03199-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
271 Vehviläinen S, Seppänen H, Nurmi A, Haglund C, Mustonen H, Udd M, Kylänpää L. Use of self-expandable metallic stents for endoscopic biliary decompression decreases stent complications in pancreatic cancer patients receiving chemotherapy. Surg Endosc 2021. [PMID: 33534073 DOI: 10.1007/s00464-021-08327-y] [Reference Citation Analysis]
272 Tentes AK. Hyperthermic intra-operative intraperitoneal chemotherapy as an adjuvant to pancreatic cancer resection. J Gastrointest Oncol 2021;12:S91-8. [PMID: 33968429 DOI: 10.21037/jgo-20-46] [Reference Citation Analysis]
273 AlMasri SS, Zenati MS, Desilva A, Nassour I, Boone BA, Singhi AD, Bartlett DL, Liotta LA, Espina V, Loughran P, Lotze MT, Paniccia A, Zeh HJ 3rd, Zureikat AH, Bahary N. Encouraging long-term survival following autophagy inhibition using neoadjuvant hydroxychloroquine and gemcitabine for high-risk patients with resectable pancreatic carcinoma. Cancer Med 2021;10:7233-41. [PMID: 34559451 DOI: 10.1002/cam4.4211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
274 Jiggens E, Mortoglou M, Grant GH, Uysal-Onganer P. The Role of CDK4 in the Pathogenesis of Pancreatic Cancer. Healthcare (Basel) 2021;9:1478. [PMID: 34828525 DOI: 10.3390/healthcare9111478] [Reference Citation Analysis]
275 Wittel UA, Lubgan D, Ghadimi M, Belyaev O, Uhl W, Bechstein WO, Grützmann R, Hohenberger WM, Schmid A, Jacobasch L, Croner RS, Reinacher-Schick A, Hopt UT, Pirkl A, Oettle H, Fietkau R, Golcher H. Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma - results of the Conko-007 multicenter trial. BMC Cancer 2019;19:979. [PMID: 31640628 DOI: 10.1186/s12885-019-6148-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
276 Naeli P, Pourhanifeh MH, Karimzadeh MR, Shabaninejad Z, Movahedpour A, Tarrahimofrad H, Mirzaei HR, Bafrani HH, Savardashtaki A, Mirzaei H, Hamblin MR. Circular RNAs and gastrointestinal cancers: Epigenetic regulators with a prognostic and therapeutic role. Crit Rev Oncol Hematol 2020;145:102854. [PMID: 31877535 DOI: 10.1016/j.critrevonc.2019.102854] [Cited by in Crossref: 83] [Cited by in F6Publishing: 85] [Article Influence: 27.7] [Reference Citation Analysis]
277 Zeng X, Zhu X, Tian Q, Tan X, Sun N, Yan M, Zhao J, Wu X, Li R, Zhang Z, Zeng H. Celastrol-conjugated chitosan oligosaccharide for the treatment of pancreatic cancer. Drug Deliv 2022;29:89-98. [PMID: 34964425 DOI: 10.1080/10717544.2021.2018521] [Reference Citation Analysis]
278 Perales S, Torres C, Jimenez-Luna C, Prados J, Martinez-Galan J, Sanchez-Manas JM, Caba O. Liquid biopsy approach to pancreatic cancer. World J Gastrointest Oncol 2021; 13(10): 1263-1287 [PMID: 34721766 DOI: 10.4251/wjgo.v13.i10.1263] [Reference Citation Analysis]
279 Hansen SEJ, Langsted A, Varbo A, Madsen CM, Tybjærg-Hansen A, Nordestgaard BG. Low and high pancreatic amylase is associated with pancreatic cancer and chronic pancreatitis. Eur J Epidemiol 2021;36:975-84. [PMID: 34482515 DOI: 10.1007/s10654-021-00801-0] [Reference Citation Analysis]
280 Dai C, Rennhack JP, Arnoff TE, Thaker M, Younger ST, Doench JG, Huang AY, Yang A, Aguirre AJ, Wang B, Mun E, O'Connell JT, Huang Y, Labella K, Talamas JA, Li J, Ilic N, Hwang J, Hong AL, Giacomelli AO, Gjoerup O, Root DE, Hahn WC. SMAD4 represses FOSL1 expression and pancreatic cancer metastatic colonization. Cell Rep 2021;36:109443. [PMID: 34320363 DOI: 10.1016/j.celrep.2021.109443] [Reference Citation Analysis]
281 Nagalo BM, Breton CA, Zhou Y, Arora M, Bogenberger JM, Barro O, Steele MB, Jenks NJ, Baker AT, Duda DG, Roberts LR, Russell SJ, Peng KW, Borad MJ. Oncolytic Virus with Attributes of Vesicular Stomatitis Virus and Measles Virus in Hepatobiliary and Pancreatic Cancers. Mol Ther Oncolytics 2020;18:546-55. [PMID: 32839735 DOI: 10.1016/j.omto.2020.08.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
282 Ng KYY, Chow EWX, Jiang B, Lim C, Goh BKP, Lee SY, Teo JY, Tan DMY, Cheow PC, Ooi LLPJ, Chow PKH, Lee JJX, Kam JH, Koh YX, Jeyaraj PR, Tan EK, Choo SP, Chan CY, Chung AYF, Tai D. Resected pancreatic adenocarcinoma: An Asian institution's experience. Cancer Rep (Hoboken) 2021;:e1393. [PMID: 33939335 DOI: 10.1002/cnr2.1393] [Reference Citation Analysis]
283 Kalayarasan R, Narayanan S, Sahoo J, Mohan P. Impact of surgery for chronic pancreatitis on the risk of pancreatic cancer: Untying the Gordian knot. World J Gastroenterol 2021; 27(27): 4371-4382 [PMID: 34366610 DOI: 10.3748/wjg.v27.i27.4371] [Reference Citation Analysis]
284 Chekmarev J, Azad MG, Richardson DR. The Oncogenic Signaling Disruptor, NDRG1: Molecular and Cellular Mechanisms of Activity. Cells 2021;10:2382. [PMID: 34572031 DOI: 10.3390/cells10092382] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
285 Luo Y, Hu J, Liu Y, Li L, Li Y, Sun B, Kong R. Invadopodia: A potential target for pancreatic cancer therapy. Crit Rev Oncol Hematol 2021;159:103236. [PMID: 33482351 DOI: 10.1016/j.critrevonc.2021.103236] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
286 Guo Y, Czeyda-Pommersheim F, Miccio JA, Mahalingam S, Cecchini M, Pahade J. Can a simplified CT response criteria for vascular involvement in pancreatic adenocarcinoma after neoadjuvant therapy predict survival in patients who achieved subsequent R0 resection? Abdom Radiol (NY) 2021;46:5609-17. [PMID: 34557934 DOI: 10.1007/s00261-021-03284-5] [Reference Citation Analysis]
287 Kane LE, Mellotte GS, Conlon KC, Ryan BM, Maher SG. Multi-Omic Biomarkers as Potential Tools for the Characterisation of Pancreatic Cystic Lesions and Cancer: Innovative Patient Data Integration. Cancers (Basel) 2021;13:769. [PMID: 33673153 DOI: 10.3390/cancers13040769] [Reference Citation Analysis]
288 Quinn PL, Ohioma D, Jones AMK, Ahlawat SK, Chokshi RJ. Treatment of Rare and Aggressive Pancreatic Carcinosarcoma. ACG Case Rep J. 2020;7:e00379. [PMID: 32607379 DOI: 10.14309/crj.0000000000000379] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
289 Peisl S, Mellenthin C, Vignot L, Gonelle-Gispert C, Bühler L, Egger B. Therapeutic targeting of STAT3 pathways in pancreatic adenocarcinoma: A systematic review of clinical and preclinical literature. PLoS One 2021;16:e0252397. [PMID: 34138876 DOI: 10.1371/journal.pone.0252397] [Reference Citation Analysis]
290 Ou A, Zhao X, Lu Z. The potential roles of p53 signaling reactivation in pancreatic cancer therapy. Biochim Biophys Acta Rev Cancer 2021;1877:188662. [PMID: 34861354 DOI: 10.1016/j.bbcan.2021.188662] [Reference Citation Analysis]
291 Batista S, Gregório AC, Hanada Otake A, Couto N, Costa-Silva B. The Gastrointestinal Tumor Microenvironment: An Updated Biological and Clinical Perspective. J Oncol 2019;2019:6240505. [PMID: 31885581 DOI: 10.1155/2019/6240505] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
292 Sadighbayan D, Sadighbayan K, Khosroushahi AY, Hasanzadeh M. Recent advances on the DNA-based electrochemical biosensing of cancer biomarkers: Analytical approach. TrAC Trends in Analytical Chemistry 2019;119:115609. [DOI: 10.1016/j.trac.2019.07.020] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
293 Morani AC, Hanafy AK, Ramani NS, Katabathina VS, Yedururi S, Dasyam AK, Prasad SR. Hereditary and Sporadic Pancreatic Ductal Adenocarcinoma: Current Update on Genetics and Imaging. Radiol Imaging Cancer 2020;2:e190020. [PMID: 33778702 DOI: 10.1148/rycan.2020190020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
294 Cura Daball P, Tröger H, Daum S. [Long-term response in advanced pancreatic adenocarcinoma - a case report and literature review]. Z Gastroenterol 2021. [PMID: 34905798 DOI: 10.1055/a-1695-3528] [Reference Citation Analysis]
295 Xie Q, Wang L, Zheng S. Prognostic and Clinicopathological Significance of C-Reactive Protein to Albumin Ratio in Patients With Pancreatic Cancer: A Meta-Analysis. Dose Response 2020;18:1559325820931290. [PMID: 32647499 DOI: 10.1177/1559325820931290] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
296 Aoyama R, Hori T, Yamamoto H, Harada H, Yamamoto M, Yamada M, Yazawa T, Sasaki B, Tani M, Sato A, Katsura H, Kamada Y, Tani R, Sasaki Y, Zaima M. A Thought-Provoking Case of Successfully Treated Carcinoma of the Head of the Pancreas with Metachronous Lung Metastasis: Impact of Distal Spleno-Renal Shunt for Regional Invasion on Long-Term Period after Pancreaticoduodenectomy. Case Rep Surg 2021;2021:6689419. [PMID: 34136302 DOI: 10.1155/2021/6689419] [Reference Citation Analysis]
297 Zhang J, Sun H, Liu S, Huang W, Gu J, Zhao Z, Qin H, Luo L, Yang J, Fang Y, Ge J, Ni B, Wang H. Alteration of tumor-associated macrophage subtypes mediated by KRT6A in pancreatic ductal adenocarcinoma. Aging (Albany NY) 2020;12:23217-32. [PMID: 33221741 DOI: 10.18632/aging.104091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
298 Zhang M, Hu X, Kang Y, Xu W, Yang X. Association between fasting blood glucose levels at admission and overall survival of patients with pancreatic cancer. BMC Cancer 2021;21:131. [PMID: 33549043 DOI: 10.1186/s12885-021-07859-9] [Reference Citation Analysis]
299 Pratt HG, Steinberger KJ, Mihalik NE, Ott S, Whalley T, Szomolay B, Boone BA, Eubank TD. Macrophage and Neutrophil Interactions in the Pancreatic Tumor Microenvironment Drive the Pathogenesis of Pancreatic Cancer. Cancers (Basel) 2021;14:194. [PMID: 35008355 DOI: 10.3390/cancers14010194] [Reference Citation Analysis]
300 Arias-Pinilla GA, Dalgleish AG, Mudan S, Bagwan I, Walker AJ, Modjtahedi H. Development and application of two novel monoclonal antibodies against overexpressed CD26 and integrin α3 in human pancreatic cancer. Sci Rep 2020;10:537. [PMID: 31953437 DOI: 10.1038/s41598-019-57287-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
301 Cheng T, Zhang Z, Shen H, Jian Z, Li J, Chen Y, Shen Y, Dai X. Topically applicated curcumin/gelatin-blended nanofibrous mat inhibits pancreatic adenocarcinoma by increasing ROS production and endoplasmic reticulum stress mediated apoptosis. J Nanobiotechnology 2020;18:126. [PMID: 32891174 DOI: 10.1186/s12951-020-00687-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
302 Zhang T, Li M, Lu H, Peng T. Up-Regulation of circEIF6 Contributes to Pancreatic Cancer Development Through Targeting miR-557/SLC7A11/PI3K/AKT Signaling. Cancer Manag Res 2021;13:247-58. [PMID: 33469368 DOI: 10.2147/CMAR.S280307] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
303 Fu H, Mi W, Pan B, Guo Y, Li J, Xu R, Zheng J, Zou C, Zhang T, Liang Z, Zou J, Zou H. Automatic Pancreatic Ductal Adenocarcinoma Detection in Whole Slide Images Using Deep Convolutional Neural Networks. Front Oncol 2021;11:665929. [PMID: 34249702 DOI: 10.3389/fonc.2021.665929] [Reference Citation Analysis]
304 Sun X, He X, Zhang Y, Hosaka K, Andersson P, Wu J, Wu J, Jing X, Du Q, Hui X, Ding B, Guo Z, Hong A, Liu X, Wang Y, Ji Q, Beyaert R, Yang Y, Li Q, Cao Y. Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism. Gut 2021:gutjnl-2020-322744. [PMID: 33568427 DOI: 10.1136/gutjnl-2020-322744] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
305 Li T, Ren T, Huang C, Li Y, Yang P, Che G, Luo L, Chen Y, Peng S, Lin Y, Zeng L. S100A16 induces epithelial-mesenchymal transition in human PDAC cells and is a new therapeutic target for pancreatic cancer treatment that synergizes with gemcitabine. Biochem Pharmacol 2021;189:114396. [PMID: 33359364 DOI: 10.1016/j.bcp.2020.114396] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
306 Baig MS, Roy A, Rajpoot S, Liu D, Savai R, Banerjee S, Kawada M, Faisal SM, Saluja R, Saqib U, Ohishi T, Wary KK. Tumor-derived exosomes in the regulation of macrophage polarization. Inflamm Res 2020;69:435-51. [DOI: 10.1007/s00011-020-01318-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 39] [Article Influence: 16.0] [Reference Citation Analysis]
307 Meyer A, Carvalho BJ, Medeiros KA, Pipek LZ, Nascimento FS, Suzuki MO, Munhoz JV, Iuamoto LR, Carneiro-D'Alburquerque LA, Andraus W. Change in neoadjuvant chemotherapy could alter the prognosis of patients with pancreatic adenocarcinoma: A case report. World J Clin Cases 2021; 9(14): 3418-3423 [PMID: 34002153 DOI: 10.12998/wjcc.v9.i14.3418] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
308 Kimura N, Yamada S, Takami H, Murotani K, Yoshioka I, Shibuya K, Sonohara F, Hoshino Y, Hirano K, Watanabe T, Baba H, Mori K, Miwa T, Kanda M, Hayashi M, Matsui K, Okumura T, Kodera Y, Fujii T. Optimal Preoperative Multidisciplinary Treatment in Borderline Resectable Pancreatic Cancer. Cancers (Basel) 2020;13:E36. [PMID: 33374369 DOI: 10.3390/cancers13010036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
309 Kasi A, McGinnis T, Naik G, Handa S, Williams G, Paluri R. Efficacy and tolerability of the combination of nano-liposomal irinotecan and 5-fluorouracil/leucovorin in advanced pancreatic adenocarcinoma: post-approval clinic experience. J Gastrointest Oncol 2021;12:464-73. [PMID: 34012640 DOI: 10.21037/jgo-20-338] [Reference Citation Analysis]
310 Fei N, Wen S, Ramanathan R, Hogg ME, Zureikat AH, Lotze MT, Bahary N, Singhi AD, Zeh HJ, Boone BA. SMAD4 loss is associated with response to neoadjuvant chemotherapy plus hydroxychloroquine in patients with pancreatic adenocarcinoma. Clin Transl Sci 2021. [PMID: 34002944 DOI: 10.1111/cts.13029] [Reference Citation Analysis]
311 Hanna-Sawires RG, Schiphuis JH, Wuhrer M, Vasen HFA, van Leerdam ME, Bonsing BA, Mesker WE, van der Burgt YEM, Tollenaar RAEM. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer. Int J Mol Sci 2021;22:2655. [PMID: 33800786 DOI: 10.3390/ijms22052655] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
312 Ahmed AA, Marchetti C, Ohnmacht SA, Neidle S. A G-quadruplex-binding compound shows potent activity in human gemcitabine-resistant pancreatic cancer cells. Sci Rep 2020;10:12192. [PMID: 32699225 DOI: 10.1038/s41598-020-68944-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
313 Sharma V, Aggarwal A, Jacob J, Sahni D. Myeloid-derived suppressor cells: Bridging the gap between inflammation and pancreatic adenocarcinoma. Scand J Immunol 2021;93:e13021. [PMID: 33455004 DOI: 10.1111/sji.13021] [Reference Citation Analysis]
314 He XF, Xiao YY, Zhang X, Zhang XB, Zhang X, Wei YT, Zhang ZL, Wiggermann P. Preliminary clinical application of the robot-assisted CT-guided irreversible electroporation ablation for the treatment of pancreatic head carcinoma. Int J Med Robot 2020;16:e2099. [PMID: 32112493 DOI: 10.1002/rcs.2099] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
315 Waldenmaier M, Seibold T, Seufferlein T, Eiseler T. Pancreatic Cancer Small Extracellular Vesicles (Exosomes): A Tale of Short- and Long-Distance Communication. Cancers (Basel) 2021;13:4844. [PMID: 34638330 DOI: 10.3390/cancers13194844] [Reference Citation Analysis]
316 Liu K, Song S, Fu T, Liu Y, Zhang H, Yan M, He Z, Zhang W, Su H, Li Z, Ji Z, Shao Z. Spatiotemporal Trends in the Incidence of Gastrointestinal Neoplasms in Wuwei City of Northwestern China From 1995 to 2016: A Hospital-Based Retrospective Observational Study. Front Oncol 2021;11:712857. [PMID: 34552871 DOI: 10.3389/fonc.2021.712857] [Reference Citation Analysis]
317 Gupta N, Yelamanchi R. Pancreatic adenocarcinoma: A review of recent paradigms and advances in epidemiology, clinical diagnosis and management. World J Gastroenterol 2021; 27(23): 3158-3181 [PMID: 34163104 DOI: 10.3748/wjg.v27.i23.3158] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
318 Mantini G, Meijer LL, Glogovitis I, In 't Veld SGJG, Paleckyte R, Capula M, Le Large TYS, Morelli L, Pham TV, Piersma SR, Frampton AE, Jimenez CR, Kazemier G, Koppers-Lalic D, Wurdinger T, Giovannetti E. Omics Analysis of Educated Platelets in Cancer and Benign Disease of the Pancreas. Cancers (Basel) 2020;13:E66. [PMID: 33383671 DOI: 10.3390/cancers13010066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
319 Parama D, Boruah M, Yachna K, Rana V, Banik K, Harsha C, Thakur KK, Dutta U, Arya A, Mao X, Ahn KS, Kunnumakkara AB. Diosgenin, a steroidal saponin, and its analogs: Effective therapies against different chronic diseases. Life Sci 2020;260:118182. [PMID: 32781063 DOI: 10.1016/j.lfs.2020.118182] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
320 Luo X, Yu B, Jiang N, Du Q, Ye X, Li H, Wang WQ, Zhai Q. Chemotherapy-Induced Reduction of Neutrophil-to-Lymphocyte Ratio Is Associated With Better Survival in Pancreatic Adenocarcinoma: A Meta-Analysis. Cancer Control 2020;27:1073274820977135. [PMID: 33269614 DOI: 10.1177/1073274820977135] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
321 Jadid MFS, Shademan B, Chavoshi R, Seyyedsani N, Aghaei E, Taheri E, Goleij P, Hajazimian S, Karamad V, Behroozi J, Sabet MN, Isazadeh A, Baradaran B. Enhanced anticancer potency of hydroxytyrosol and curcumin by PLGA-PAA nano-encapsulation on PANC-1 pancreatic cancer cell line. Environ Toxicol 2021;36:1043-51. [PMID: 33496383 DOI: 10.1002/tox.23103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
322 Chen J, Zhao CC, Chen FR, Feng GW, Luo F, Jiang T. KIF20B Promotes Cell Proliferation and May Be a Potential Therapeutic Target in Pancreatic Cancer. J Oncol 2021;2021:5572402. [PMID: 34539784 DOI: 10.1155/2021/5572402] [Reference Citation Analysis]
323 Zeng H, Zhu X, Tian Q, Yan Y, Zhang L, Yan M, Li R, Li X, Wang G, Ma J, Su Y, Zhang X, Ma L, Zhang Z, Wu X. In vivo antitumor effects of carboxymethyl chitosan-conjugated triptolide after oral administration. Drug Deliv 2020;27:848-54. [PMID: 32508161 DOI: 10.1080/10717544.2020.1770370] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
324 Li WP, Yen CJ, Wu BS, Wong TW. Recent Advances in Photodynamic Therapy for Deep-Seated Tumors with the Aid of Nanomedicine. Biomedicines 2021;9:69. [PMID: 33445690 DOI: 10.3390/biomedicines9010069] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
325 Maekawa H, Ito T, Orita H, Kushida T, Sakurada M, Sato K, Hulbert A, Brock MV. Analysis of the methylation of CpG islands in the CDO1, TAC1 and CHFR genes in pancreatic ductal cancer. Oncol Lett 2020;19:2197-204. [PMID: 32194717 DOI: 10.3892/ol.2020.11340] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
326 Nie HX, Zhang L, He T, Wang L, Wan BS, Wang XQ, Han F. lncRNA-XLOC_012370 Promotes the Development of Pancreatic Cancer and Inactivates the NF-κB Pathway Through miR-140-5p. Front Oncol 2020;10:620550. [PMID: 33708618 DOI: 10.3389/fonc.2020.620550] [Reference Citation Analysis]
327 Bai K, Zhao T, Li Y, Li X, Zhang Z, Du Z, Wang Z, Xu Y, Sun B, Bai X. Integrating Genetic and Transcriptomic Data to Reveal Pathogenesis and Prognostic Markers of Pancreatic Adenocarcinoma. Front Genet 2021;12:747270. [PMID: 34567094 DOI: 10.3389/fgene.2021.747270] [Reference Citation Analysis]
328 Lu S, Liang J, Liao S, Wu D, Wu F, Li H. Use of MRI signal intensity ratio to differentiate between autoimmune pancreatitis and pancreatic ductal adenocarcinoma. Clin Radiol 2022;77:e84-91. [PMID: 34756699 DOI: 10.1016/j.crad.2021.10.003] [Reference Citation Analysis]
329 Zhang Q, Lv L, Ma P, Zhang Y, Deng J, Zhang Y. Identification of an Autophagy-Related Pair Signature for Predicting Prognoses and Immune Activity in Pancreatic Adenocarcinoma. Front Immunol 2021;12:743938. [PMID: 34956177 DOI: 10.3389/fimmu.2021.743938] [Reference Citation Analysis]
330 Mollinedo F, Gajate C. Direct Endoplasmic Reticulum Targeting by the Selective Alkylphospholipid Analog and Antitumor Ether Lipid Edelfosine as a Therapeutic Approach in Pancreatic Cancer. Cancers (Basel) 2021;13:4173. [PMID: 34439330 DOI: 10.3390/cancers13164173] [Reference Citation Analysis]
331 Sun S, Liu Y, He C, Hu W, Liu W, Huang X, Wu J, Xie F, Chen C, Wang J, Lin Y, Zhu W, Yan G, Cai J, Li S. Combining NanoKnife with M1 oncolytic virus enhances anticancer activity in pancreatic cancer. Cancer Lett 2021;502:9-24. [PMID: 33444691 DOI: 10.1016/j.canlet.2020.12.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
332 Ferreira PMP, Sousa RWR, Ferreira JRO, Militão GCG, Bezerra DP. Chloroquine and hydroxychloroquine in antitumor therapies based on autophagy-related mechanisms. Pharmacol Res 2021;168:105582. [PMID: 33775862 DOI: 10.1016/j.phrs.2021.105582] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
333 Yao J, Zhang C, Chen Y, Gao S. Downregulation of circular RNA circ-LDLRAD3 suppresses pancreatic cancer progression through miR-137-3p/PTN axis. Life Sciences 2019;239:116871. [DOI: 10.1016/j.lfs.2019.116871] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
334 Watanabe S, Miyoshi J, Toki M, Kambayashi K, Kitada S, Nosaka T, Goto T, Ota H, Ochiai K, Gondo K, Ikeuchi N, Tsuji S, Nakamura K, Shibahara J, Hisamatsu T. Effectiveness of introducing a 20-gauge core biopsy needle with a core trap in EUS-FNA/B for diagnosing pancreatic cancer. BMC Gastroenterol 2021;21:8. [PMID: 33407181 DOI: 10.1186/s12876-020-01583-7] [Reference Citation Analysis]
335 Huang CT, Lin CK, Lee TH, Liang YJ. Pancreatic Fibrosis and Chronic Pancreatitis: Mini-Review of Non-Histologic Diagnosis for Clinical Applications. Diagnostics (Basel) 2020;10:E87. [PMID: 32045995 DOI: 10.3390/diagnostics10020087] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
336 Beirith I, Renz BW, Mudusetti S, Ring NS, Kolorz J, Koch D, Bazhin AV, Berger M, Wang J, Angele MK, D'Haese JG, Guba MO, Niess H, Andrassy J, Werner J, Ilmer M. Identification of the Neurokinin-1 Receptor as Targetable Stratification Factor for Drug Repurposing in Pancreatic Cancer. Cancers (Basel) 2021;13:2703. [PMID: 34070805 DOI: 10.3390/cancers13112703] [Reference Citation Analysis]
337 Fu Z, Liang X, Shi L, Tang L, Chen D, Liu A, Shao C. SYT8 promotes pancreatic cancer progression via the TNNI2/ERRα/SIRT1 signaling pathway. Cell Death Discov 2021;7:390. [PMID: 34907162 DOI: 10.1038/s41420-021-00779-4] [Reference Citation Analysis]
338 Rajesh S, Cox MJ, Runau F. Molecular advances in pancreatic cancer: A genomic, proteomic and metabolomic approach . World J Gastroenterol 2021; 27(31): 5171-5180 [PMID: 34497442 DOI: 10.3748/wjg.v27.i31.5171] [Reference Citation Analysis]
339 Caputo D, Caracciolo G. Nanoparticle-enabled blood tests for early detection of pancreatic ductal adenocarcinoma. Cancer Lett. 2020;470:191-196. [PMID: 31783084 DOI: 10.1016/j.canlet.2019.11.030] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
340 Gonzalez-Mancera MS, Ahmadian SS, Gomez-Fernandez C, Velez-Torres J, Jorda M, García-Buitrago MT. Risk of malignancy associated with the diagnostic categories proposed by the Papanicolaou Society of Cytopathology for pancreaticobiliary specimens: An institutional experience. Diagn Cytopathol 2021. [PMID: 34856075 DOI: 10.1002/dc.24910] [Reference Citation Analysis]
341 Malhotra L, Goyal HKV, Jhuria S, Dev K, Kumar S, Kumar M, Kaur P, Ethayathulla AS. Curcumin rescue p53Y220C in BxPC-3 pancreatic adenocarcinomas cell line: Evidence-based on computational, biophysical, and in vivo studies. Biochim Biophys Acta Gen Subj 2021;1865:129807. [PMID: 33278547 DOI: 10.1016/j.bbagen.2020.129807] [Reference Citation Analysis]
342 Zou W, Wang Z, Wang F, Zhang G, Liu R. A nomogram predicting overall survival in patients with non-metastatic pancreatic head adenocarcinoma after surgery: a population-based study. BMC Cancer 2021;21:524. [PMID: 33964898 DOI: 10.1186/s12885-021-08250-4] [Reference Citation Analysis]
343 Bangs FK, Miller P, O'Neill E. Ciliogenesis and Hedgehog signalling are suppressed downstream of KRAS during acinar-ductal metaplasia in mouse. Dis Model Mech 2020;13:dmm044289. [PMID: 32571902 DOI: 10.1242/dmm.044289] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
344 [DOI: 10.1101/2021.01.13.426413] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
345 Lu C, Fan L, Zhang PF, Tao WW, Yang CB, Shang EX, Chen FY, Che CT, Cheng HB, Duan JA, Zhao M. A novel P38α MAPK activator Bruceine A exhibits potent anti-pancreatic cancer activity. Comput Struct Biotechnol J 2021;19:3437-50. [PMID: 34194669 DOI: 10.1016/j.csbj.2021.06.011] [Reference Citation Analysis]
346 Lincha VR, Zhao J, Wen X, Xiong C, S-L Chow D, Li C. A polymeric micellar drug delivery system developed through a design of Experiment approach improves pancreatic tumor accumulation of calcipotriol and paclitaxel. Int J Pharm 2021;601:120523. [PMID: 33775721 DOI: 10.1016/j.ijpharm.2021.120523] [Reference Citation Analysis]
347 Beetz O, Sarisin A, Kaltenborn A, Klempnauer J, Winkler M, Grannas G. Multivisceral resection for adenocarcinoma of the pancreatic body and tail-a retrospective single-center analysis. World J Surg Oncol 2020;18:218. [PMID: 32819373 DOI: 10.1186/s12957-020-01973-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
348 Gowthami J, Gururaj N, Mahalakshmi V, Sathya R, Sabarinath TR, Doss DM. Genetic predisposition and prediction protocol for epithelial neoplasms in disease-free individuals: A systematic review. J Oral Maxillofac Pathol 2020;24:293-307. [PMID: 33456239 DOI: 10.4103/jomfp.JOMFP_348_19] [Reference Citation Analysis]
349 Powell-Brett S, Pande R, Roberts KJ. Achieving 'Marginal Gains' to Optimise Outcomes in Resectable Pancreatic Cancer. Cancers (Basel) 2021;13:1669. [PMID: 33916294 DOI: 10.3390/cancers13071669] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
350 Kumar AA, Buckley BJ, Ranson M. The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets. Biomolecules 2022;12:152. [DOI: 10.3390/biom12020152] [Reference Citation Analysis]
351 Xu H, Li Y, Paxton JW, Wu Z. Co-Delivery Using pH-Sensitive Liposomes to Pancreatic Cancer Cells: the Effects of Curcumin on Cellular Concentration and Pharmacokinetics of Gemcitabine. Pharm Res 2021;38:1209-19. [PMID: 34189639 DOI: 10.1007/s11095-021-03072-2] [Reference Citation Analysis]
352 Sung MK, Park Y, Kwak BJ, Jun E, Lee W, Song KB, Lee JH, Hwang DW, Kim SC. Comparison of Characteristics and Survival Rates of Resectable Pancreatic Ductal Adenocarcinoma according to Tumor Location. Biomedicines 2021;9:1706. [PMID: 34829935 DOI: 10.3390/biomedicines9111706] [Reference Citation Analysis]
353 Testa A, Venturelli E, Brizzi MF. Extracellular Vesicles as a Novel Liquid Biopsy-Based Diagnosis for the Central Nervous System, Head and Neck, Lung, and Gastrointestinal Cancers: Current and Future Perspectives. Cancers (Basel) 2021;13:2792. [PMID: 34205183 DOI: 10.3390/cancers13112792] [Reference Citation Analysis]
354 Rogers JE, Mizrahi JD, Nogueras Gonzalez GM, Surana R, Shroff RT, Wolff R, Varadhachary GR, Javle MM, Overman M, Raghav K, Pant S. Outcomes of patients with metastatic pancreatic cancer who progress on first restaging imaging. J Gastrointest Oncol 2021;12:2268-74. [PMID: 34790391 DOI: 10.21037/jgo-20-569] [Reference Citation Analysis]
355 Zhang M, He S, Ma X, Ye Y, Wang G, Zhuang J, Song Y, Xia W. GINS2 affects cell viability, cell apoptosis, and cell cycle progression of pancreatic cancer cells via MAPK/ERK pathway. J Cancer 2020;11:4662-70. [PMID: 32626512 DOI: 10.7150/jca.38386] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
356 Liu L, Liu TX, Huang WX, Yang Z, Wang S, Da MX, Dong Y. Distal pancreatectomy with En-bloc celiac axis resection for locally advanced pancreatic body/tail cancer: A systematic review and meta-analysis. Asian J Surg 2021:S1015-9584(21)00325-0. [PMID: 34187724 DOI: 10.1016/j.asjsur.2021.06.002] [Reference Citation Analysis]
357 Chao J, Jin L, Zhang X, Ding D, Wu S, Ma L, Zhu B, Shan S, Yun X, Gao P, Li J, Zhu C, Qin X. Insight into the effects of microRNA-23a-3p on pancreatic cancer and its underlying molecular mechanism. Oncol Lett 2020;19:187-94. [PMID: 31897129 DOI: 10.3892/ol.2019.11117] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
358 Guruprasad P, Lee YG, Kim KH, Ruella M. The current landscape of single-cell transcriptomics for cancer immunotherapy. J Exp Med 2021;218:e20201574. [PMID: 33601414 DOI: 10.1084/jem.20201574] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
359 Desai D, Khandwala P, Parsi M, Potdar R. PARP inhibitors: shifting the paradigm in the treatment of pancreatic cancer. Med Oncol 2021;38:61. [PMID: 33891252 DOI: 10.1007/s12032-021-01507-9] [Reference Citation Analysis]
360 Huang W, Hua H, Xiao G, Yang X, Yang Q, Jin L. ZC3HAV1 promotes the proliferation and metastasis via regulating KRAS in pancreatic cancer. Aging (Albany NY) 2021;13:18482-97. [PMID: 34319912 DOI: 10.18632/aging.203296] [Reference Citation Analysis]
361 Ichikawa S, Kromrey ML, Motosugi U, Onishi H. Optimal target b-value on computed diffusion-weighted magnetic resonance imaging for visualization of pancreatic ductal adenocarcinoma and focal autoimmune pancreatitis. Abdom Radiol (NY) 2021;46:636-46. [PMID: 32740865 DOI: 10.1007/s00261-020-02695-0] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
362 Hilmi M, Neuzillet C. Nouvelle AMM : olaparib — cancer du pancréas avec mutation germinale de BRCA. Bulletin du Cancer 2020;107:961-2. [DOI: 10.1016/j.bulcan.2020.06.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
363 Meleti M, Cassi D, Vescovi P, Setti G, Pertinhez TA, Pezzi ME. Salivary biomarkers for diagnosis of systemic diseases and malignant tumors. A systematic review. Med Oral Patol Oral Cir Bucal 2020;25:e299-310. [PMID: 32040469 DOI: 10.4317/medoral.23355] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
364 Wang K, Miao X, Kong F, Huang S, Mo J, Jin C, Zheng Y. Integrating Network Pharmacology and Experimental Verification to Explore the Mechanism of Effect of Zuojin Pills in Pancreatic Cancer Treatment. Drug Des Devel Ther 2021;15:3749-64. [PMID: 34511884 DOI: 10.2147/DDDT.S323360] [Reference Citation Analysis]
365 Hsieh A, Pitarresi JR, Lerner J, Donahue G, Hsiehchen D, Rustgi AK, Zaret K. Growth of pancreatic cancers with hemizygous chromosomal 17p loss of MYBBP1A can be preferentially targeted by PARP inhibitors. Sci Adv 2020;6:eabc4517. [PMID: 33277249 DOI: 10.1126/sciadv.abc4517] [Reference Citation Analysis]
366 Schweber AB, Agarunov E, Brooks C, Hur C, Gonda TA. Prevalence, Incidence, and Risk of Progression of Asymptomatic Pancreatic Cysts in Large Sample Real-world Data. Pancreas 2021;50:1287-92. [PMID: 34860813 DOI: 10.1097/MPA.0000000000001918] [Reference Citation Analysis]
367 Azari H, Mousavi P, Karimi E, Sadri F, Zarei M, Rafat M, Shekari M. The expanding role of CDR1-AS in the regulation and development of cancer and human diseases. J Cell Physiol 2021;236:771-90. [PMID: 32697389 DOI: 10.1002/jcp.29950] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
368 Natesh NS, White BM, Bennett MMC, Uz M, Kalari Kandy RR, Batra SK, Mallapragada SK, Rachagani S. Emerging Role of miR-345 and Its Effective Delivery as a Potential Therapeutic Candidate in Pancreatic Cancer and Other Cancers. Pharmaceutics 2021;13:1987. [PMID: 34959269 DOI: 10.3390/pharmaceutics13121987] [Reference Citation Analysis]
369 Zheng C, Zhang T, Li D, Huang C, Tang H, Ni XF, Chen B. Upregulation of CENPM facilitates tumor metastasis via the mTOR/p70S6K signaling pathway in pancreatic cancer. Oncol Rep 2020;44:1003-12. [PMID: 32705259 DOI: 10.3892/or.2020.7673] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
370 Yang Y, Cheng T, Xie P, Wang L, Chen H, Cheng Z, Zhou J. PMEPA1 interference activates PTEN/PI3K/AKT, thereby inhibiting the proliferation, invasion and migration of pancreatic cancer cells and enhancing the sensitivity to gemcitabine and cisplatin. Drug Dev Res 2021. [PMID: 34189738 DOI: 10.1002/ddr.21844] [Reference Citation Analysis]
371 O'Neill EJ, Hartogh DJD, Azizi K, Tsiani E. Anticancer Properties of Carnosol: A Summary of in Vitro and In Vivo Evidence. Antioxidants (Basel) 2020;9:E961. [PMID: 33049974 DOI: 10.3390/antiox9100961] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
372 Xu J, Zhang W. EZR promotes pancreatic cancer proliferation and metastasis by activating FAK/AKT signaling pathway. Cancer Cell Int 2021;21:521. [PMID: 34627255 DOI: 10.1186/s12935-021-02222-1] [Reference Citation Analysis]
373 Zhu L, Ren S, Daniels MJ, Qiu W, Song L, You T, Wang D, Wang Z. Exogenous HMGB1 Promotes the Proliferation and Metastasis of Pancreatic Cancer Cells. Front Med (Lausanne) 2021;8:756988. [PMID: 34805222 DOI: 10.3389/fmed.2021.756988] [Reference Citation Analysis]
374 Deftereos I, Kiss N, Isenring E, Carter VM, Yeung JM. A systematic review of the effect of preoperative nutrition support on nutritional status and treatment outcomes in upper gastrointestinal cancer resection. European Journal of Surgical Oncology 2020;46:1423-34. [DOI: 10.1016/j.ejso.2020.04.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
375 Bukhari N, Abdalla K, Ibnshamsa F, Alselwi W, Al-Shakir S, Alqahtani M. Exceptional Response to Second-Line Gemcitabine/Nab-Paclitaxel Chemotherapy in Patients With Metastatic Pancreatic Adenocarcinoma. Cureus 2021;13:e18756. [PMID: 34796055 DOI: 10.7759/cureus.18756] [Reference Citation Analysis]
376 Jang HJ, Yang JH, Hong E, Jo E, Lee S, Lee S, Choi JS, Yoo HS, Kang H. Chelidonine Induces Apoptosis via GADD45a-p53 Regulation in Human Pancreatic Cancer Cells. Integr Cancer Ther 2021;20:15347354211006191. [PMID: 33884928 DOI: 10.1177/15347354211006191] [Reference Citation Analysis]
377 Chen L, Xu Z, Li Q, Feng Q, Zheng C, Du Y, Yuan R, Peng X. USP28 facilitates pancreatic cancer progression through activation of Wnt/β-catenin pathway via stabilising FOXM1. Cell Death Dis 2021;12:887. [PMID: 34584067 DOI: 10.1038/s41419-021-04163-z] [Reference Citation Analysis]
378 Chen X, Zhao H, Chen C, Li J, He J, Fu X, Zhao H. The HPA/SDC1 axis promotes invasion and metastasis of pancreatic cancer cells by activating EMT via FGF2 upregulation. Oncol Lett 2020;19:211-20. [PMID: 31897132 DOI: 10.3892/ol.2019.11121] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
379 Rah B, Banday MA, Bhat GR, Shah OJ, Jeelani H, Kawoosa F, Yousuf T, Afroze D. Evaluation of biomarkers, genetic mutations, and epigenetic modifications in early diagnosis of pancreatic cancer. World J Gastroenterol 2021; 27(36): 6093-6109 [PMID: 34629822 DOI: 10.3748/wjg.v27.i36.6093] [Reference Citation Analysis]
380 Holbrook MC, Goad DW, Grdzelishvili VZ. Expanding the Spectrum of Pancreatic Cancers Responsive to Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Challenges and Solutions. Cancers (Basel) 2021;13:1171. [PMID: 33803211 DOI: 10.3390/cancers13051171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
381 Mollinedo F, Gajate C. Novel therapeutic approaches for pancreatic cancer by combined targeting of RAF→MEK→ERK signaling and autophagy survival response. Ann Transl Med 2019;7:S153. [PMID: 31576360 DOI: 10.21037/atm.2019.06.40] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
382 Ratajczak K, Glatzel-Plucińska N, Ratajczak-Wielgomas K, Nowińska K, Borska S. Effect of Resveratrol Treatment on Human Pancreatic Cancer Cells through Alterations of Bcl-2 Family Members. Molecules 2021;26:6560. [PMID: 34770968 DOI: 10.3390/molecules26216560] [Reference Citation Analysis]
383 Zhang Y, Yang J, Wang X, Li X. GNG7 and ADCY1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma through bioinformatic-based analyses. Sci Rep 2021;11:20441. [PMID: 34650124 DOI: 10.1038/s41598-021-99544-x] [Reference Citation Analysis]
384 Cheng J, Lou Y, Jiang K. Downregulation of long non-coding RNA LINC00460 inhibits the proliferation, migration and invasion, and promotes apoptosis of pancreatic cancer cells via modulation of the miR-320b/ARF1 axis. Bioengineered 2021;12:96-107. [PMID: 33345740 DOI: 10.1080/21655979.2020.1863035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
385 Martín-Blázquez A, Jiménez-Luna C, Díaz C, Martínez-Galán J, Prados J, Vicente F, Melguizo C, Genilloud O, Pérez Del Palacio J, Caba O. Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics. Cancers (Basel) 2020;12:E1002. [PMID: 32325731 DOI: 10.3390/cancers12041002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
386 Deng Y, Xia X, Zhao Y, Zhao Z, Martinez C, Yin W, Yao J, Hang Q, Wu W, Zhang J, Yu Y, Xia W, Yao F, Zhao D, Sun Y, Ying H, Hung MC, Ma L. Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance. Nat Commun 2021;12:7041. [PMID: 34873175 DOI: 10.1038/s41467-021-27349-7] [Reference Citation Analysis]
387 Arias-Pinilla GA, Modjtahedi H. Therapeutic Application of Monoclonal Antibodies in Pancreatic Cancer: Advances, Challenges and Future Opportunities. Cancers (Basel) 2021;13:1781. [PMID: 33917882 DOI: 10.3390/cancers13081781] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
388 Narayanan S, AlMasri S, Zenati M, Nassour I, Chopra A, Rieser C, Smith K, Oyefusi V, Daum T, Bahary N, Bartlett D, Lee K, Zureikat A, Paniccia A. Predictors of early recurrence following neoadjuvant chemotherapy and surgical resection for localized pancreatic adenocarcinoma. J Surg Oncol 2021;124:308-16. [PMID: 33893740 DOI: 10.1002/jso.26510] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
389 Nehlsen AD, Goodman KA. Controversies in radiotherapy for pancreas cancer. J Surg Oncol 2021;123:1460-6. [PMID: 33831248 DOI: 10.1002/jso.26313] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
390 Bundred JR, Kamarajah SK, Hammond JS, Wilson CH, Prentis J, Pandanaboyana S. Prehabilitation prior to surgery for pancreatic cancer: A systematic review. Pancreatology. 2020;20:1243-1250. [PMID: 32826168 DOI: 10.1016/j.pan.2020.07.411] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
391 Xia P, Liu P, Fu Q, Liu C, Luo Q, Zhang X, Cheng L, Qin T, Zhang H. Long noncoding RNA EPIC1 interacts with YAP1 to regulate the cell cycle and promote the growth of pancreatic cancer cells. Biochemical and Biophysical Research Communications 2020;522:978-85. [DOI: 10.1016/j.bbrc.2019.11.167] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
392 Henry KE, Shaffer TM, Mack KN, Ring J, Ogirala A, Klein-Scory S, Eilert-Micus C, Schmiegel W, Bracht T, Sitek B, Clyne M, Reid CJ, Sipos B, Lewis JS, Kalthoff H, Grimm J. Exploiting the MUC5AC Antigen for Noninvasive Identification of Pancreatic Cancer. J Nucl Med 2021;62:1384-90. [PMID: 33712530 DOI: 10.2967/jnumed.120.256776] [Reference Citation Analysis]
393 Ratajczak K, Borska S. Cytotoxic and Proapoptotic Effects of Resveratrol in In Vitro Studies on Selected Types of Gastrointestinal Cancers. Molecules 2021;26:4350. [PMID: 34299624 DOI: 10.3390/molecules26144350] [Reference Citation Analysis]
394 Elsayed M, Abdelrahim M. The Latest Advancement in Pancreatic Ductal Adenocarcinoma Therapy: A Review Article for the Latest Guidelines and Novel Therapies. Biomedicines 2021;9:389. [PMID: 33917380 DOI: 10.3390/biomedicines9040389] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
395 Laoveeravat P, Thavaraputta S, Vutthikraivit W, Suchartlikitwong S, Mingbunjerdsuk T, Motes A, Nugent K, Rakvit A, Islam E, Islam S. Proton pump inhibitors and histamine-2 receptor antagonists on the risk of pancreatic cancer: a systematic review and meta-analysis. QJM 2020;113:100-7. [PMID: 31503318 DOI: 10.1093/qjmed/hcz234] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
396 Huang J, Mao Q, Sun X. Identification of a DNA repair 9-gene signature for the overall survival prediction of pancreatic cancer. Annals of Diagnostic Pathology 2022. [DOI: 10.1016/j.anndiagpath.2021.151883] [Reference Citation Analysis]
397 Harmon CE, Lamsal SP, Harmon TS, Mohamed K, Meyer TE. The Path of Most Resistance: A Rare Instance of Metastatic Pancreatic Adenocarcinoma Identified Within Skeletal Muscle. Cureus 2021;13:e13947. [PMID: 33880284 DOI: 10.7759/cureus.13947] [Reference Citation Analysis]
398 Gutierrez-Sainz L, Viñal D, Villamayor J, Martinez-Perez D, Garcia-Cuesta JA, Ghanem I, Custodio A, Feliu J. Prognostic factors in advanced pancreatic ductal adenocarcinoma patients-receiving second-line treatment: a single institution experience. Clin Transl Oncol 2021;23:1838-46. [PMID: 33866520 DOI: 10.1007/s12094-021-02589-7] [Reference Citation Analysis]
399 Timmer FEF, Geboers B, Nieuwenhuizen S, Dijkstra M, Schouten EAC, Puijk RS, de Vries JJJ, van den Tol MP, Bruynzeel AME, Streppel MM, Wilmink JW, van der Vliet HJ, Meijerink MR, Scheffer HJ, de Gruijl TD. Pancreatic Cancer and Immunotherapy: A Clinical Overview. Cancers (Basel) 2021;13:4138. [PMID: 34439292 DOI: 10.3390/cancers13164138] [Reference Citation Analysis]
400 Zhang Z, Zhu R, Sun W, Wang J, Liu J. Analysis of Methylation-driven Genes in Pancreatic Ductal Adenocarcinoma for Predicting Prognosis. J Cancer 2021;12:6507-18. [PMID: 34659542 DOI: 10.7150/jca.53208] [Reference Citation Analysis]
401 Pijnappel EN, Wassenaar NPM, Gurney-Champion OJ, Klaassen R, van der Lee K, Pleunis-van Empel MCH, Richel DJ, Legdeur MC, Nederveen AJ, van Laarhoven HWM, Wilmink JW. Phase I/II Study of LDE225 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer. Cancers (Basel) 2021;13:4869. [PMID: 34638351 DOI: 10.3390/cancers13194869] [Reference Citation Analysis]